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I NTROOUCTI ON
The Dutch physician, Eijkmann, originally detected thiamin as
a nutritional factor required for the prevention of pylyneuritis (1).
The historical events surrounding the isolation and structural determination of thiamin have been previously reviewed (1 ).
Thiamin diphosphate (pyrophosphate)
vitamin.

1

is the active form of this

This fact was first discovered in 1937 when Lohmann and Schus-

ter (2) characterized thiamin diphosphate as a coenzyme for yeast pyruvate decarboxylase, (EC 4.1. 1 .1).

Since 1937, thiamin diphosphate has

also been shown to be an essential coenzyme for pyruvate dehydrogenase
(EC 1.2.4.1) (3), alpha ketoglutarate dehydrogenase (EC 1.2.4.2) (4),
transketolase (EC 2.2.1.1) (5,6,7), phosphoketolase (EC 4.1.2.9) (8),
and the oxidative decarboxylation of glyoxylic acid (9).
The objective of this study is to obtain more knowledge concerning
the conversion of thiamin to thiamin diphosphate in pig brain.

This is

to be done by purifying pig brain thiamin pyrophosphokinase (ATP: thiamin pyrophosphotransferase, EC 2.7.6.2), studying some of its properties,
and the effects of some thiamin antagonists upon it.
Role of Thiamin Diphosphate
As can be seen from the above list of enzymes which require TOP
for activity, it is essential for carbohydrate metabolism.

Thus far,

1The abbreviations used are: TOP, thiamin diphosphate, TPK,
thiamin pyrophosphokinase.

2

TOP has been found to participate in three general types of reaction
(10):

(1) non-oxidative decarboxylation of o<-keto acids, (2) oxida-

tive decarboxylations of
(acyloins).

O(,..keto acids, and (3) formation of 0(.-ketols

An example of the first type of reaction is the decarbox-

ylation of pyruvic acid by yeast pyruvate decarboxylase.
TDP

pyruvate

acetaldehyde

( 1)

+

The second type of reaction is well illustrated by the alpha keto acid
dehydrogenases of mammalian tissue.

These reactions can be formulated

as follows:
0

II

R-C-OH

+

(2)

+

As shown in reaction 2, oxygen is the ultimate oxidizing agent; however, in most cases, the immediate oxidizing agent is lipoic acid.
The third type of reaction is illustrated by the formation of
acetoin from pyruvate:

'
A different example of
ketolase reaction.

+

2CO

2

(3)

o<.-ketol formation is illustrated by the trans-

This reaction involves the transfer of a two-

carbon fragment, from a ketose, to an aldose--for example:
xylulose-5-phosphate

+

ribose-5-phosphate

sedoheptulose-7-phosphate

+

glyceraldehyde-3-phosphate (4)

In the above example the sedoheptulose-7-phosphate contains the newly
formed

0(-ketol

0 OH

(-~-C-).

Both yeast apopyruvate decarboxylase and apotransketolase have
been used to detect TOP produced by the thiamin pyrophosphokinase

3

reaction (11, 12).

Thus, they have been used to assay for TPK activity.

The effects of thiamin deficiency and thiamin antagonists (especially
pyrithiamin and oxythiamin) on the various thiamin-dependent enzymes
and their substrates and products have been extensively studied in vivo.
Some of the earliest experiments on the effects of thiamin deficiency were carried out by Peters (13) and his colleagues using pigeons.
They found a large increase in lactic acid in the brains of thiamin
deficient pigeons.

At first they thought thiamin was directly involved

in lactate oxidation.

Later it was noted that there was also an abnor-

mal amount of pyruvate in the blood and brain of the thiamin deficient
pigeons.

For a short time there was uncertainty as to whether the thi-

amin was involved in the oxidation of lactate or pyruvate.

It was fin-

ally established, on the basis of studies of the oxygen uptake on addition of thiamin, that the vitamin was utilized in the oxidation of pyruvate, not lactate--McGowan (14) found that the ratio of oxygen uptake
to pyruvate lost was significantly lowered in thiamin deficient pigeon
brains as compared to normal birds.

This strengthened the conclusion

that thiamin was essential in the oxidation of pyruvate.

While attempt-

ing to elucidate the pathway of complete pyruvate oxidation, McGowan
and Peters (15) studied the increased oxygen uptake when thiamin was
added with

mixtures of pyruvate and other acids to tissue homogenates.

The addition of the other acids had no effect on oxygen uptake by tissue homogenates of either normal or thiamin deficient pigeons.

It was

concluded from this experiment that the pathway of pyruvate oxidation
did not involve either of the tested acids { o<.-ketoglutarate and succinate).

4

Gubler (16,17) has studied the effects of thiamin deprivation
on the rate of oxidative decarboxylation of several
homogenates of various rat tissues.

o(-keto acids in

He found that pyruvate oxidation

in liver mitochondria, kidney homogenates, and heart homogenates was
significantly lowered by thiamin deprivation.

However, the rate of

oxidation could be restored to normal by adding TOP.

This indicated

that the lowered oxidation rates were due to a deficiency of TOP.
bably this deficiency was caused by a simple lack of thiamin.

Pro-

The rate

of pyruvate oxidation in brain homogenates was not affected by thiamin
deprivation.

Gubler 1 s data on the oxidation of o(_-ketoglutarate by tis-

sue homogenates of thiamin deficient rats was the same as that discussed for pyruvate.

That is, the rate of oxidation, as compared to con-

trol rats, was lowered in liver, kidney, and heart, but not in brain.
Recently thiamin deficiency, as produced by feeding thiamin antagonists (oxythiamin and pyrithiamin), has been studied in an attempt
to gain more understanding of the role of thiamin in metabolism.

The

structures of the various thiamin antagonist used in this study are
listed in Table 1.
Pyrithiamin has been shown to be a very potent antithiamin agent
and has been extensively used to study thiamin deficiency.

DeCaro,

Rindi, and Grana (74) found that intraperitoneal injection of pyrithiamin caused a reduction in the total thiamin content of liver, muscle,
and brain of rats.

After only five days of pyrithiamin treatment, the

total thiamin content of the brain was found to be about half that in
brains of rats which were on a thiamin deficient diet for twenty three
days.

These data proved that pyrithiamin was much more effective than

thiamin deficiency in reducing the thiamin content of brain.

5

TAB LE 1

STRUCTURES OF THIAMIN AND SOME THIAMIN ANTAGONISTS

NA/CH2

H,
N+

'H

Name

z

\

H3 C

R

\

CH2
I
CH2
I
OH
z

X

Thiamin

CH3

s

Pyrithiamin

NH 2

CH3

CH=CH

Oxythiamin

NH 2

CH3

OH

s

Butylthiamin

n-C4H9

s

Ethylthiamin

CH 2cH

NH 2

3

NH 2

s
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Pyrithiamin was also found to be more effective than thiamin deficiency
in reducing the total thiamin content of liver and muscle; the change
wasn't as dramatic as in the case of, qrain.
DeCaro

~- (75) reported that when equimolar amounts of either

pyrithiamin or oxythiamin were administered to rats by intraperitoneal
injection, the former antagonist was much more potent in causing a reduction in the thiamin levels of the tissues studied (liver, muscle,
and brain).

They also noted that both antagonists caused an increase

in the amount of thiamin excreted in the urine of the treated rats.
This is a further indication that the tissue levels of thiamin were
being reduced during the treatment by the thiamin antagonists.

The

amount of thiamin in the urine of rats treated with pyrithiamin was
ten to twenty times more than eliminated by controls, whereas the
increase in urinary thiamin due to oxythiamin treatment was only 1.4
to 2,9 times that of controls .
Gubler (16) observed that daily subcutaneous injections of pyrithiamin and thiamin at a ratio of 5:1 was sufficient to cause convulsions and death.

Other workers have administered the antagonist in

the diet (18) and found similar results.

Gubler (16,17) observed that

the pyrithiamin-antagonized rats had decreased ability to oxidize pyruvate in liver mitochondria and in kidney, heart, and brain homogenates.

In at least the liver, brain, and kidney the administration of

TOP could largely restore the values to normal.
given for the heart.

There were no data

The pyrithiamin treatment also caused a decrease

in the ability to oxidize

o(.-ketoglutarate in all the tissues studied

except liver mitochondria and heart homogenates.

Bennett et~- (18),

using rats antagonized by dietary pyrithiamin, found that the ability

7
to oxidize pyruvate by liver mitochondria was unimpaired; this was
also true of the ability to oxidize 0(-ketoglutarate.

The ability of

the brain homogenates of these rats to oxidize both pyruvate and o(,ketoglutarate was significantly decreased, especially in the case of
pyruvate.

The authors speculate that their results with liver mito-

chondria, which differ from those of Gubler (16), might have been
caused by their method of administration of pyrithiamin.

Since their

animals stopped eating, and thus stopped receiving the pyrithiamin
about two days prior to death, the animals were given time to excrete
the liver pyrithiamin; whereas the brain concentrates and retains pyrithiamin (19,40).

Gubler, by giving daily subcutaneous injections of

pyrithiamin, undoubtedly maintained the liver pyrithiamin concentration until the death of the animals.
Holowach

~:.!. ~-

(20) studied the effects of intraperitoneal in-

jections of pyrithiamin on mice at an antagonist to thiamin ratio of
fifty.

They found a marked decrease in both brain and liver pyruvate

and C>(-ketoglutarate dehydrogenases.

The levels of both pyruvate and

0(.-ketoglutarate in the brain were elevated, suggesting that the shunt
pathway around 0(-ketoglutarate dehydrogenase by way of
rate is not very important, at least in mouse brain.

('-amino buty-

The results ob-

tained with liver mitochondria support those of Gubler and indicate
that, unless administration of the antagonist is continued until death,
the liver is able to excrete it and thus remove the inhibition of the
pyruvate and 0(-ketoglutarate dehydrogenases.
Koedam and Steyn-Parv~ (73) found that when pyrithiamin was added
to homogenates of both pigeon breast muscle and heart, it had no effect on pyruvate dehydrogenase activity.

Pyrithiamin diphosphate,

8

however, had a definite inhibitory effect on pyruvate dehydrogenase
in the two homogenates.
Oxythiamin is another potent thiamin antagonist which has been
widely studied (see Table 1 for structure).

Gubler (16, 17) has found

that, in the case of rats, subcutaneous injections of oxythiamin at a
ratio of two hundred to one with respect to thiamin will produce many
of the signs of thiamin deficiency and eventually death.

In this

study it was found that in liver mitochondria and kidney and heart
homogenates, oxythiamin caused a decrease in the ability to oxidize
pyruvate.

In all the tissues studied (brain, heart, liver, and kid-

ney), oxythiamin decreased

o(-ketoglutarate oxidation only in the

heart; it had no effect on either pyruvate or O<.-ketoglutarate dehydrogenase in brain homogenates.

Since Gubler 1 s (16) work appeared in

1961, it has been demonstrated by Rindi et~- (21) that oxythiamin
does not penetrate the brain, which explains why it has no effect on
any of the tested brain enzymes in vivo.
Koedam and Steyn-Parv~ (73) have followed pyruvate dehydrogenase activity under anaerobic conditions by measuring the formation of
acetoin from pyruvate.
powerful inhibitor

They found that oxythiamin pyrophosphate is a

of pyruvic dehydrogenase in homogenates of pigeon

breast muscle and heart.

In fact, it proved to be a far more powerful

inhibitor than pyrithiamin pyrophosphate, oxythiamin itself appeared
to have no effect on the enzyme.

Koedam and Steyn-Parv~ (73) also found

that the addition of TOP, either before or after the addition of the
antagonist, had no effect on the observed inhibition.

This is in con-

trast to the results of similar experiments with yeast apocarboxylase

(73).

In the case of yeast apocarboxylase Koedam and Steyn-Parv~
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noted that addition of TOP previous to the addition of the antagonist, oxythiamin diphosphate, completely prevented the inhibition.
If the TOP was added after the antagonist, the inhibition was partially reversed.

This indicates that pyruvate dehydrogenase has a

higher affinity for oxythiamin diphosphate than apocarboxylase.

Of

course, the results of all the above experiments depend upon the relative amounts of antagonist and TOP used.
and Steyn-Parv~, Cerecedo

Prior to the work of Koedam

(78) also reported that yeast apocarboxylase

could be inhibited by oxythiamin diphosphate, but the inhibition could
be prevented by the addition of TOP.

Again oxythiamin itself gave no

inhibition of the enzyme.
One of the results of oxythiamin administration is anorexia, or
loss of appetite.

Bitter~~- (22) studied the effects of force

feeding during oxythiamin treatment.

They found that blood pyruvate

was increased just as in non-force-fed animals, but that the survival
time was lowered.

They also noted a large accumulation of food in the

gut of the treated animals.
of the treatment.

This fact was evident from the beginning

This suggested that the anorexia and the inability

to utilize food might be caused by some specific local disturbance in
the gut rather than a central mechanism.

Bai (23) found that the

transketolase activity of the intestinal mucosa of oxythiamin-treated
rats showed a significant decrease in the beginning of the experimental period concurrent with the beginning of weight loss and anorexia.
She also studied the pyruvate dehydrogenase activity, but found that
it showed no consistent relationship to anorexia and weight loss.

It

was concluded that perhaps intestinal transketolase plays a role in
the development of anorexia in oxythiamin-treated rats.

It should be

10
noted that Bai also found a significant, but delayed, drop in intestinal transketolase activity of thiamin deficient and pyrithiamintreated rats, concurrent with the onset of anorexia and weight loss
in these animals.

These data support the conclusion that the cause

of the anorexia may be a specific, local biochemical disturbance.
ever, recently Rindi, et al.

How-

(24) reported the results of experiments

in which oxythiamin was injected directly into the brain of rats.

They

found that the oxythiamin, when intracerebrally injected, greatly depressed the appetite.

This anorexia lasted for three days.

It was

concluded that since the effects appeared soon after intracerebral injection of oxythiamin, they are likely to be a consequence of some
central action related to the

11

feeding centers. 11

The above experiments

indicate that perhaps there is more than one way in which anorexia may
be introduced.

Unfortunately, Rindi and co-workers did not report the

effects of the oxythiamin injections on any of the enzyme levels of
either brain or gut.
Compared to the amount of work which has been done with pyrithiamin and oxythiamin, very little has been done with either butylthiamin
or ethylthiamin.

The anti-thiamin effect of butylthiamin in rats was

studied by Emerson and Southwick (79).

In this experiment both thiamin

and the antagonist were administered by stomach tube.

It was reported

that rats maintained on five ug of thiamin, plus 2.8 mg of butylthiamin per day (ratio of thiamin to antagonist of 1/560), all developed
polyneuritis.

The control rats, rats on a thiamin deficient diet, rats

fed only butylthiamin (2.8 mg per day), and rats which were fed fifty
ug thiamin and 2.8 mg butylthiamin per day; all failed to develop polyneuritic symptoms under the conditions of the experiment.

In fact

11

when the amount of thiamin was increased to fifty ug per day, it completely nullified the anti-vitamin activity of butylthiamin.
Cerecedo (80) has used mice to compare the anti-thiamin effect
of butylthiamin with that of oxythiamin and pyrithiamin

The vari -

ous doses of thiamin and antigonists were administered by subcutaneous
injection.

It was reported that a ratio by weight of butylthiamin to

thiamin of about two hundred was required to produce symptoms of thiamin deficiency.

Using mean survival time as an index of anti-thiamin

activity, the data given show that the ratios (by weight) analog/
thiamin are:

butylthiamin:

oxythiamin:

pyrithiamin; 200:

25:

1.

It was noted that some of the butylthiamin-treated mice developed polyneuritic symptoms.

As noted above, butylthiamin-antagonized rats also

developed polyneuritic symptoms under certain conditions

(79).

The results of experiments with ethylthiamin appear to be contradictory.

On the one hand, ethylthiamin has been reported to be as ef-

fective as thiamin in promoting growth in both rats and mice (72); while,
on the other hand, the analog, or its pyrophosphate ester, has low activity compared to thiamin (or its pyrophosphate ester) in isolated
enzyme systems.

Shimizu and Makino (72) found that ethylthiamin was

as effective as thiamin in promoting the growth of mice.

Also the

authors showed that the endogenous respiration in liver homogenates of
mice fed ethylthiamin for up to two weeks was equal to that of controls.
The addition of pyruvate to both types of homogenates caused no differences in oxygen uptake.

It was also noted that ethylthiamin injections

were almost as effective as thiamin injections in prolonging the survival time of pyrithiamin-treated mice.

However, it was observed (72)

that in liver homogenates of thiamin deficient mice, added TOP had a
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larger effect on pyruvate oxidation, as measured by oxygen uptake, than
ethylthiamin pyrophosphaie.

Futhermore, brain homogenates of thiamin

deficient mice showed a larger catatorulin test with thiamin as compared to ethylthiamin.

Mano and Tanaka (56) have shown that ethylthi-

amin has a small amount of activity as a substrate for purified rat
liver TPK; but they also noted it was rather powerful as a competitive
inhibitor of thiamin in the TPK reaction (Ki = 4.1 x 10-S M).

The

means by which ethylthiamin is able to promote growth in thiamin deficient animals is still unknown, and the contradictory results cited
above cannot be explained at this time.
The Phosphorylation of Thiamin
The first discovery that TOP was the active form of thiamin was
made by Lohmann and Schuster (2) in 1937.

Since that time the phos-

phorylation of thiamin has been extensively studied.

Various thiamin

antagonists, especially oxythiamin and pyrithiamin, have been used in
an effort to gain more understanding of this process.
The effects of pyrithiamin on thiamin phosphorylation have been
widely studied because of the antagonist is able to induce the polyneuritis of thiamin deficiency.
Woolley (25) studied the synthesis of TOP from thiamin in chicken
blood and the effect of pyrithiamin on this reaction.
that pyrithiamin caused an inhibition of TOP synthesis.

He reported
However, he

was not able to decide whether the inhibition was due to the production of pyrithiamin di phosphate, which in turn would combine with and
inhibit the apodecarboxylase assay system, or whether the inhibition
was due simply to the inhibition of the TOP-synthesizing enzyme system.

13
On the basis of other experiments in which he found that the concentration of liver TOP in mice dying from the effects of pyrithiamin administration was unchanged (75), Woolley postulated that perhaps pyrithiamin antagonized some unknown function of TDP--unrelated to its action
as a coenzyme (76).

As late as 1963 Woolley still maintained (26) that

the mechanism of action of pyrithiamin was related, at least in part,
to its ability to inhibit an unknown biochemical reaction of thiamin.
DeCaro et al. (39) repeated and extended the experiments of
Woolley (76).

They reported that mice treated with pyrithiamin as

outlined by Woolley (76) (a single oral dose of 0.5 mg followed by an
oral dose of two ug of thiamin per day) showed no neurological symptoms
after ten days.

(Woolley reported (76) that all the mice developed

neurological symptoms and died within seven days).

In agreement with

Woolley (76), DeCaro !:,! ~- (39) found the total thiamin levels of
both liver and muscle unchanged by the treatment, but the total thiamin content of the brain was significantly lowered.

(Woolley had not

checked the effect of the treatment on the total thiamin content of
the brain.)

It was noted that if thiamin was withheld after the dose

of pyrithiamin, all the treated mice developed neurological symptoms
within six to ten days.

The results of DeCaro

~- (39)

• • • do not support the hypothesis of a new function of thiamin
in the nervous tissue. Actually the pyrithiamin, in the dose used,
fails to lower the thiamin level of the liver according to Woolley's (76) results, but it greatly lowers the brain content, producing neurological disturbances typical of thiamin deficiency.
Eich and Cerecedo (27) studied the effect of pyrithiamin on purified rat liver thiamin pyrophosphokinase, which was prepared according to the method of Leuthardt and Nielsen (28).

In this study it was

found that pyrithiamin definitely inhibited the phosphorylation of

I

14
thiamin to mP.

It was also noted that pyrithiamin

vitro was not

able to inhibit any of the known enzyme systems which require mP.
Cerecedo, Eich, and Bresnick (29) purified rat intestinal TPK and
found that it was greatly inhibited by pyrithiamin.
Koedam and Steyn-Parv~ (73) also found that the synthesis of mp
by rat liver TPK, prepared according to the procedure of Leuthardt and
Nielson (28), was inhibited by pyrithiamin.

They observed that when

pyrithiamin replaced thiamin in the reaction mixture, pyrithiamin pyrophosphate was formed, although the amount obtained was "very much
smaller than the amount of mp synthesized from thiamin under comparable circumstances."

These workers found essentially the same results

in experiments which utilized partially purified yeast TPK (73).

This

is the only report in which pyrithiamin pyrophosphate has been definitely identified as a product of the TPK reaction.
One of the main problems in the study of the thiamin deficiency
caused by the administration of the antagonist, pyrithiamin, is to
determine the primary biochemical cause of the symptoms of polyneuritis.
As noted above, Woolley proposed that it might be due to an inhibition
of some new physiological function of thiamin which is not related to
the role of mP as a coenzyme.

However, this question is still not

satisfactorily answered today (17).

While attempting to determine the

primary cause of the symptoms of thiamin deficiency induced by pyrithiamin, Koedam (30) confirmed the results of Eich and Cerecedo as
stated above.

(He found that pyrithiamin strongly inhibited thiamin

phosphorylation by partially purified rat liver TPK.)

Koedam believed

that the effects of pyrithiamin could be explained by the lowered levels
of mP, without postulating any new function for thiamin.

However, he

15
cautioned that the "time had not yet come to attach a causal significance to the concomitant occurrance of polyneuritic symptoms and specific disturbances to thiamin metabolism."

Koedam and Steyn-Parve (73)

felt that pyrithiamin exerted its effect either by inhibiting the
phosphorylation of thiamin, or by being phosphorylated itself to form
pyrithiamin pyrophosphate, which could then compete with TOP for active
sites of enzymes.

The authors felt the available evidence indicated

that the former possibility was of more importance than the latter in
explaining the mode of action of pyrithiamin.

Eusebi and Grecedo (31)

had reported that yeast TPK appeared to be inhibited by oxythiamin, but
not pyrithiamin.

Thus the results obtained with the rat liver system

would be diametrically opposed to those found with the yeast system.
However, Kaziro (11), using a yeast TPK preparation which had been purified one hundred-fold, found that pyrithiamin was a strong competitive
inhibitor (Ki = 8.5 x 10-5 M) of the enzyme.

He was not able to de-

cide whether pyrithiamin produced its inhibition by simply competing
at the active site of the enzyme or whether it was phosphorylated, although the evidence favored the former possibility.
Rindi and Perri (19) have studied the uptake of pyrithiamin by
various rat tissues.

They found that, for up to twelve days after a

single large intraperitoneal dose, the pyrithiamin concentration in
the brain rose, whereas that in other organs fell after twenty-four
hours.

When the

pyrithiamin was given as a daily oral dose, the con-

centration in all tissues studied rose for the duration of the experiment (twenty days).

An interesting aspect of this work was found in

the assay of pyrithiamin.

In order to do the fluorometric assay, the

pyrithiamin first had to be extracted, as the pyrichrome, by
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isobutanol.

It was found by Rindi and Perri, and has been confirmed

in this laboratory (unpublished experiments), that before the pyrithiamin can be extracted, it must first be treated with Taka-diastase,
indicating that most of the pyrithiamin present in the tissues is in
a phosphorylated form.

This observation, which supports the results

of Koedam and
phosphorylated by TPK.

indicates that pyrithiamin may be
Since pyrithiamin diphosphate is a relatively

weak inhibitor of TOP-requiring enzymes (17,32), it is possible that
the antithiamin effect of pyrithiamin is primarily due to competition
with thiamin for phosphorylation by TPK.
Sharma and Quastel (33) have studied the phosphorylation of thiamin in rat brain extracts and in brain slices.

They observed that py-

rithiamin inhibited the uptake of labeled thiamin by rat brain slices.
Also, they found that, in the brain extracts, the inhibition of thiamin

uptake appeared to be competitive.

Their findings indicated that phos-

phorylation might be the means by which thiamin is transported into
the brain.
Ventura and Rindi (34), studying the smal 1 intestine of the rat,
were able to demonstrate results very similar to those from the brain.
That is, pyrithiamin was able to cause a significant degree of inhibition of the transport of thiamin across the intestinal wall.

Further

studies on the transport and phosphorylation of thiamin by rat intestine

(35,36) have indicated that, although the two processes are similar,
the phosphorylation and the transport of thiamin are actually mediated
by two different systems.

Ventura, et~- (35) give the Km's for both

processes as well as the Ki's for pyrithiamin.
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Johnson and Gubler (12) have reported that purified rat brain TPK
is strongly inhibited by pyrithiamin, which is in agreement with the
results from brain which were reported by Sharma and Quastel (33),
Since many of the neurological signs of thiamin deficiency, as
produced by pyrithiamin administration, appear to be the result of
pyrithiamin accumulation in the brain, Rindi and Scioelli have studied
the effects of injecting pyrithiamin directly into the brain (37),

They

found that pyrithiamin injection caused a transitory increase (lasting
less than one day) in free thiamin, and a more lasting decrease in the
phosphorylated thiamin content, especially at the higher doses (0.6
umole) of pyrithiamin.

It was also noted that the injections caused

symptoms of neurological disorder in the rats.

However, these symptoms

were not the same as those elicited by the dietary administration of
pyrithiamin.

The reasons for this are not clear at this time.

Unfort-

unately, the effects of these injections on the enzyme activities associated with thiamin metabolism were not studied.
In attempting to elucidate the mechanism of action of pyrithiamin,
Cooper (38) has studied the effect of the antimetabolite on the rabbit
vagus nerve.

He Found that, as with the other tissues, pyrithiamin had

no effect on the activities of the enzymes which require TOP for activity.

However, pyrithiamin was able to cause a displacement of thiamin

from the nerve.

The idea that pyrithiamin causes a displacement of

thiamin from nervous tissue is supported by the results of Rindi et al.
(21).

They believe that the neuromuscular symptoms, caused by pyrithi-

amin administration, are the result of the lowering of thiamin levels
which is brought about by the antimetabolite.

It was stated that the

mechanism by which this lowering of the thiamin concentration took place,
was unknown (39).
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An interesting aspect of the study of pyrithiamin inhibition
has been found by Sinha and Chatterjee (41), who have studied this
inhibition in the bacterium Staphylococcus aureus.
to obtain a pyrithiamin mutant(~. aureus

A)

They were able

which grew in the ab-

sence of thiamin, but it required pyrithiamin (a potent inhibitor of

1·

aureus).

Among other things, it was found that the mutant, S.

aureus A, was completely lacking in TPK, and this enzyme could not be
induced by growing the mutant in a medium containing pyrithiamin and
thiamin.
In contrast to oyrithiamin, oxythiamin has not been found +o be
a very potent inhibitor of thiamin phosphorylati0n.

Eich and Cerecedo

(27) found that oxythiamin di phosphate would inhibit carboxylase iso
lated from wheat germ, as long as it was added at the sa~e time or before the TOP.

However, they also found that oxythiamin was a rather

weak inhibitor of a partially purified rat liver TPK preparation.

Cere-

cedo, Eich, and Bresnick (29) found that oxythiamin was also a weak
inhibitor of TPK from rat intestine.

Woolley (20) theorized that oxy-

thiamin was phosphorylated by the TPK to oxythiamin diphosphate, which
could then act as an inhibitor to any TOP-requiring enzymes.
Koedam and Steyn-Parve~have reported (73) that even a one hundredfold excess of oxythiamin as compared to th;amin has no effect on the
synthesis of TOP by rat liver TPK.

In similar experiments with yeast

TPK only a small decrease in the amount of TOP synthesized was noted.
These exoeriments suooort the theory that oxythiamin is n0t effecti,e
in inhibiting the synthesis of TOP by TPK.

The results of K0edam and

Steyn-Parve"support earlier observati0ns of Cerecedo (78) on the effect
of oxythiamin on TOP synthesis by rat liver TPK.

The observed inhibition
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of rat liver TPK

by pyrithiamin, and lack of the same by oxythiamin,

suggested to Cerecedo (78)

11

•

that the presence of an amino group

in position four (substituent X in Table 1) of the pyrimidine moiety
might be necessary for inhibition of the enzyme."

In order to test

this hypothesis, the 4-hydroxy derivative of pyrithiamin was prepared
(see Table 1--the NH 2 at position X would be replaced by OH).

This

compound, oxypyrithiamin, had no effect on the synthesis of TOP by rat
liver TPK even when present in one hundred-fold excess over thiamin.
Oxypyrithiamin was administered by subcutaneous injection along with
thiamin to mice to determine if it had any antithiamin activity in
vivo.

It was found that the growth rate of mice was not affected by

this treatment.

Under similar in vivo conditions oxythiamin shows

considerable antithiamin activity

(78).

It was concluded from these

experiments that the amino group in position four on the pyrimidine
ring is necessary in order to inhibit the phosphorylation of thiamin
by rat liver TPK.

It was also felt, on the basis of these experiments

that the thiazole ring is necessary in order to have antithiamin activity in vivo, at least when the amino group on the pyrimidine ring is
replaced by a hydroxyl group.
Ventura and Rindi (34) noted that oxythiamin was ineffective in
inhibiting thiamin transport in rat intestine.

This finding was ascrib-

ed to the inability of oxythiamin to inhibit thiamin phosphorylation.
Rindi, de Giuseppe and Ventura (21), were able to develop methods
whereby they could assay tissue extracts for the presence of oxythiamin
and its phosphate esters.

They were able to show that rat tissue had

the ability to phosphorylate oxythiamin to the diphosphate.

This find-

ing was explained by assuming that, under conditions of low thiamin
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concentration, oxythiamin is able to act as a substrate for the TPK of
the tissue.

They stated that the amount of oxythiamin diphosphate

formed didn't depend so much on the ratio of oxythiamin to thiamin,
but rather on the absolute amount of thiamin introduced.

It was also

noted that no oxythiamin diphosphate was found in the brains of the
rats.

This was believed to be caused by the inability of oxythiamin

to cross the blood brain barrier.
The above findings of Rindi and co-workers were confirmed and
strengthened to some extent by the work of Johnson and Gubler (12,17).
Using a partially purified preparation of rat brain TPK, they were
able to show that it could synthesize an oxythiamin inhibitor of transketolase.

This inhibitor could not be synthesized without the addition

of enzyme and ATP.

The addition of thiamin prevented the formulation

of this inhibitor.

It was assumed that the brain enzyme was able to

synthesize oxythiamin diphosphate from oxythiamin and ATP.
Yeast TPK is quite similar to the mammalian enzymes discussed
thus far with respect to its behavior towards oxythiamin.

For example,

Kaziro (11), using yeast TPK which had been purified one hundred-fold
over the original extract, found that oxythiamin was a weak competitive
inhibitor (Ki = 1 x 10- 2 M).
It also appears that bacterial TPK will conform to the same general pattern of the mammalian and yeast TPK 1 s.

Sinha and Chatterjee

(41) found that TPK from Staphylococcus aureus was only weakly inhibited by oxythiamin.
One of the more interesting questions about the effects of oxythiamin is--if oxythiamin was able to penetrate the brain, would it
cause the type of polyneuritic symptoms that pyrithiamin does?

Recently
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an attempt has been made to answer this question by Rindi and coworkers (24,42) who have reported the results of exper imen ts in which
oxythiamin was injected directly into the brains of rats.

Although the

largest injections caused the rats to become slightly spastic for a
short time, and made some of them restless and irritable, so that sometimes they had convulsive fits, the symptoms were quite different from
beri-beri symptoms.

The oxythiamin injections also had very little ef-

fect on the content of either free or phosphorylated thiamin in the
brain.

This is in contrast to the effects of pyrithiamin similarly

injected (37).

However, it should be noted that even the direct in-

jection of pyrithiamin (37) did not cause the same type of polyneuritis
that the slower, oral administration of pyrithiamin did.

This was

thought to be because, in the rats used, the rest of the body would
have a normal thiamin content; which would be utilized by the brain
to counteract the effects of the antagonist.

This could also have made

a difference in the effects of the injected oxythiamin.

It would be

both interesting and worthwhile to study the effects of oxythiamin injection into the brains of rats that were previously made thiamin deficient.

Unfortunately, in the above study, none of the TOP depend-

ent enzyme activities were checked to see if any of them were aff ected
by the treatment.
Thiamin Pyrophosphokinase Preparations
Early in the study of the functions of IDP, it was recognized
that tissues requiring TOP would need to have an enzyme system available for synthesizing it from thiamin.

In 1939, Goodhart and Sinclair

(43) found that the IDP of the blood was entirely within the blood
cells.

Therefore they concluded (43) that
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• • • it seems unlikely that the vitamin is carried to the tissues
by the blood in the phosphorylated form. It is much more probable
that the readily diffusible vitamin BJ, which has been demonstrated
to be present throughout the blood, is the direct scource of both
the vitamin 81 and the cocarboxylase (TOP) of the fixed tissue
cell.
Even before this time, it had been found that certain tissues had the
ability to synthesize TOP from thiamin (44).

Since 1939 many schemes

have appeared in the literature for the purification of TPK from a
wide variety of cells and tissues.
One of the first attempts to purify TPK was carried out by WeilMalherbe (45).

He was able to achieve about a five-fold purification

of TPK from yeast.

With this preparation, he was able to determine

that the synthesis of TOP was dependent on ATP and he also found that
only a few ug of TOP were produced.

He noted that thiamin monophos-

phate was phosphorylated to TOP more slowly than thiamin; and suggested,
as a result of this observation, that the phosphorylation of thiamin
to TOP occurred in one step.
Steyn-Parv~ (46) reported an eight-fold purification of TPK from
yeast.

It was found that the TOP production in this enzyme system was

dependent on ATP, divalent cations, and, of course, thiamin.
most effective cation was found to be Mg++.

The

The enzyme was found to

have a broad pH optimum, extending between about 6.5 and 7.5.

Steyn-

Parve also reported that thiamin monophosphate was phosphorylated more
slowly than thiamin, in agreement with the results of Weil-Malherbe
(see above), but she interpreted this to mean that the yeast system
she was using could carry out the phosphorylation of both compounds at
different rates.
Kaziro (11) has reported a one hundred-fold purification of
yeast TPK and has studied its properties in a detailed manner.

He
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was able to absolutely show that TOP was produced by the reaction.
Also, in a large scale experiment, it was shown that the reaction was
stoichiometric with 0.31 umole of TOP being produced along with 0,33
umole of AMP.

The Michaelis constants, Km, were found to be 1 x 10-

for ATP and 0,75 x 10- 4 M for thiamin.

4M

Three divalent cations, Mn++,

Co++, and Mg++ were found to be quite effective.

The highest activity

was found at pH 8.6, with ATP as the phosphate donor and Mn++ as the
divalent cation.

The question of how the effectiveness of the di-

valent cations were influenced by pH, concentration, buffer, nucleotide species, and nucleotide concentration was explored in great detail

(47,48).

It was found that all nucleoside triphosphates were

effective as phosphate donors, but each had its own rate and optimal
conditions.

It is interesting to note that each nucleotide had an

optimal metal concentration and that the activity fell off, rather
sharply, on either side of this optimum.

This indicates that the

actual substrate for the reaction is the nucleotide metal complex.
Of course, the formation of the complex would be dependent on the concentrations of both nucleotide and metal, as well as pH.
the dependence of the reaction on these factors.

This explains

Kaziro also studied

the effects of some thiamin antagonists on the TPK reaction.

He found

that pyrithiamin, oxythiamin, ethylthiamin, and butylthiamin were in-

hibitors of TPK. He reported Ki's of 0.85 x 10- 4 M for pyrithiamin and
2
1 x 10- M for oxythiamin. Kaziro also used this TPK preparation to
study the mechanism of pyrophosphate transfer from ATP to thiamin.
Thoai

~- (49) have recently reported the two hundred-fold

purification of yeast TPK.

They used this preparation in an attempt

to determine the reactive groups on the enzyme, those which are involved
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1n the reaction, and the mechanism of the reaction.

They found that

sulfhydryl inhibitors, e.g. PCMB, were not very effective in inhibiting the reaction, and concluded that the sulfhydryl groups were important mainly in maintaining the structure of the enzyme.

The amino groups

were also studied and were found to be quite reactive; so it was felt
that an amino group(s) is important in the reactive center of yeast
TPK.

They tried to determine if a histidine residue was part of the

active site, but the results indicate that this was not the case.
The first attempted purification of TPK from mammalian source
was that of Leuthardt and Nielsen (28) who used rat liver for their
source of enzyme.

Before this time, the ability of various tissue pre-

parations to synthesize TOP from thiamin and ATP had been noted (see
e.g. 50).

It was reported that the liver TPK required a large excess

of ATP compared to the amount of thiamin; and that only a small amount
of TOP was formed when thiamin was replaced with thiamin monophosphate.
The authors believed that this indicated that thiamin was directly
phosphorylated to TOP.
TPK from the

11

Although Leuthdart and Nielsen purified their

soluble 11 fraction of liver homogenates (i.e. that

frac-

tion not precipitated by centrifugation at 25,000 xg), Kiessling (51,

52) found evidence that TPK is present in liver mitochondria.

He re-

ported that radioactive phosphate was incorporated into TOP when mitochondria were incubated with labeled phosphate and some source of
energy, such as pyruvate.

It was also shown that added labeled

phosphate was not incorporated into ADP or ATP.

This would indicate

that the reaction catalized by TPK in liver mitochondria is essentially
irreversible under the conditions of Kiessling's experiments.
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Mano (53,54,55,56) has extensively studied TPK purified from rat
liver.

He reaffirmed that the essential factors for the formation of

TOP were ATP, thiamin and divalent cations--such as Mg++.

Because of

the high concnetration of ATP required in the TPK reaction, it seems
likely that the reverse reaction may be favored.

However, Mano could

detect no ATP formation when TOP and AMP were incubated with the enzyme, thus indicating that there is little or no reversal of the enzymatic reaction.

It was also noted that, as in the case of the yeast

enzyme (see above and ref. 49), PCMB is not an effective inhibitor.
Mano also showed that the sluggish nature of the reaction could be
overcome by adding an ATP generating system, such as phosphoenolpyruvate plus pyruvate kinase.

The results indicated that the slow-down of

the reaction was due to a build up of inhibitory products, such as AMP
and ADP.

Mano was able to obtain a one hundred and twenty-fold puri-

fication of the rat liver TPK (55).

This preparation was estimated to

be about sixty-eight per cent pure, based on electrophoretic analysis
in a Tiselius 1 apparatus.

The properties of this purified rat liver

TPK were extensively studied by Mano and Tanaka (56).

Metallic ions,

effective as the essential activator, were Mg++, Mn++, Co++, and Ni++.
As in the case of the yeast enzyme (see above and ref. 47), the ions
had definite molar optimum relations to the nucleotides used.

Unlike

the yeast system, however, nucleotides useful as a pyrophosphate donor
were restricted to ATP and UTP.

Among the thiamin antagonists, ethyl-

thiamin, butylthiamin, and pyrithiamin acted as competitive inhibitors

with Ki 1 s of 4. 1 x 10 - 5, 4.3 x 10- 5 , and 3.3 x 10- 5 M, respectively .

Oxythiamin was noted to be a weak inhibitor, but the type of inhibition
caused, and its Ki, were not given.

Michaelis constants for thiamin
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. 1y.
and ATP were given as 4 .5 x 10- 7 and 8 .3 x 10 - 4 respective
values were obtained for crude enzyme preparations only.

These

The values

for the highly purified enzyme were not given.
Dues, Blum, and Holzer (57) reported the preparation of rat
liver TPK using essentially the same procedure as Mano (55).

The

procedure differed mainly in the use of a radiometric assay for TPK.
They noted that there was a clearly defined optimum concentration of
ATP as well as Mg++.

The ratios of the concentrations of Mg++ to ATP,

for optimum activity, was found to be 0.67.
Johnson and Gubler (12,17,32) have reported the partial purification of rat brain TPK.

The brain enzyme was purified twelve-fold

by a procedure very similar to that used by Mano (55) for the purification of rat liver TPK.

The brain enzyme was found to have a pH op-

timum of 7.8 in glycylglycine buffer.

for thiamin, 0.12 x 10- 6 M.

The Km for ATP was 0.02 Mand

0xythiamin and pyrithiamin were found to

be competitive inhibitors of brain TPK with Ki's of 1.5 x 10
0.2 x 10- 6 M respectively.

-4 and

The effects of different metal ions and

nucleotides were not studied.

Although they did not attempt to puri-

fy rat brain TPK, Sharma and Quastel (33) reported a Km of 2 x 10- 6 M
for the phosphorylation of thiamin in the brain extracts.

They also

reported that pyrithiamin acts as a potent, competitive inhibitor of
thiamin phosphorylation.
Although the phosphorylation of thiamin in the intestine has
been reported (see above), no attempt has been made to purify the
enzyme from this source.

Recently Gassmann and Sandner (58) have re-

ported properties of mouse pancreatic juice TPK.
pH optima at 9.0 and 5.3.

This enzyme had two

At the higher pH, the Km for the th i amin
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was 5.42 x 10-5 M, and for ATP, 1,7 x 10- 4 M.

At the lower pH, the

Km's were 1,7 x 10- 4 and 1.23 x 10- 4 M for ATP and thiamin respectively.
No attempts were made to purify and study this enzyme further . .
The preparation of purified pig heart TPK was reported by Suzuoki
et~- (36), but they gave none of its properties, except the Km for
thiamin (which was 6 x 10- 7 M).

Recently Minoru (59) has reported a

highly purified preparation of TPK from pig heart.

The enzyme was

purified about one thousand-fold over the original extracts.

That is,

undoubtedly, the purest preparation of TPK that has been obtained thus
far.

The purified preparation was homogenous on ultracentrifugation

and electrophoresis.

The molecular weight was found to be about 63,000.

The enzyme was activated by Mg++, Zn++, and Co++ and could utilize
either ATP or UTP as the pyrophosphate donor (note the similarity to
the rat liver enzyme--see above and ref. 56).
by both oxythiamin and pyrithiamin.

The enzyme was inhibited

The results of the amino acid

analysis are also given.
Although no attempts have yet been made to purify bacterial TPK,
its activity has been detected in~- coli (60) and~- aureus (41 ).
The TPK inf• coli (60) is found in the "membrane fraction" after the
cells have been disrupted by sonic oscillation, and is thought to be
involved in thiamin transport into the bacterial cell.

The apparent

Km for thiamin phosphorylation by this enzyme is 7 x 10-7 M.
Mechanism of the TPK Reaction
There has been very little work done to determine the mechanism
of the TPK reaction thus far.

This has probably been due to the lack

of purified enzyme preparations.

However, many early workers (see e.g.

45) correctly guessed that the reaction involved the direct transfer
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of pyrophosphate from ATP to thiamin, without the formation of any
intermediate thiamin monophosphate.

These predictions were made on

the basis of experiments in which thiamin was found to be phosphorylated to TDP at a faster rate than thiamin monophosphate.

Later, with

more purified preparations of TPK, it was found that thiamin monophosphate was not phosphorylated to TDP at all, thus lending support to
the theory of direct pyrophosphate transfer.

Thus far, Kaziro (61,62)

and co-workers have been the only ones to show, conclusively, that a
pyrophosphate group is transferred from ATP to thiamin.

For their ex-

periments, they used purified yeast TPK as the enzyme source and ATP-

t _3 2P.

to./1 P atom of

The ATP used had an activity ratio of¥

11.5/1.

The TDP synthesized by this system had an activity ratio of/3 too(P
atom of 11.5/1, indicating that the mechanism is as follows:
+

Th

ARP1

(5)

+

The above experiments do not tell whether the group transferred
is a pyrophosphate or a pyrophosphoryl group, although by analogy with
other transphosphorylating enzymes, it would appear that the latter is
a more reasonable mechanism.

At the present time it is not possible

to distinguish whether the enzyme catalyzes the direct combination of
the substrates, or if there is an enzyme-bound pyrophosphoryl intermediate, so that the mechanism would be as follows:
ATP

+

E

PP-E

+

AMP

(6)

PP-E

+

Th~~~--===-

TPP

+

E

(7)

Thoai and co-workers (49) have attempted to determine, kinetically, if there is an enzyme-bound intermediate in the reaction.
also utilized a purified yeast TPK preparation.

They

The results of their

experiments indicate that the reaction proceeds by what would be called
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a "ping-pong" mechanism, using the nomenclature of Cleland (63).

If

the TPK reaction does proceed by a "ping-pong" mechanism, it would
require that an intermediate enzyme pyrophosphoryl complex' be formed
so that the mechanism would be similar to that given in equations six
and seven.

More work needs to be done to clarify the mechanism of

the TPK reaction, especially with TPK from marrmalian sources.

It is

hoped that the availablity of purified mammalian TPK will stimulate
this work.

MATERIALS AND EQUIPMENT
Materials
The disodium salt of adenosine-5 1 -triphosphate (assay 99%),
pyrithiamin hydrobromide, oxythiamin hydrochloride, thiamin hydrochloride and glycylglycine, (free base) were obtained from Sigma
Chemical company, St. Louis, Missouri.
as all others, were reagent grade.

These compounds, as wel 1

Thiamin (thiazole-2-Cl4) hydro-

chloride (from batches 3, 5, 6, 7, and 8) was obtained from Amersham/
Searle, Arlington Heights, Illinois.
Amberlite CG 50, 200-400 mesh, chromatographic grade cation
exchange resin, was obtained from Mallinckrodt Chemical Works, St.
Louis, Missouri.

Sephadex G-25 and G-100 modified dextran gels were

obtained from Pharmacia Fine Chemicals, Inc., Piscataway, N.J.
Ampholine carrier ampholytes with pH ranges of 3 to 5, 3 to 6,
and 3 to 10 were obtained from LKB Instruments, Inc., Rockville, Maryland.
+

Standard phosphate buffer, pH= 7,00 - 0.01 at 25

0

was purchased

from Uni-Tech Chemical Manufacturing Co., Sun Valley, California.
The pig brains were obtained gratuitously from Bartholomew
Slaughter House, Springville, Utah.

The brains were removed with-

in forty-five to seventy-five minutes after the death of the animal,
and were irrrnediately placed in ice and kept at o0 unti 1 the acetone
powder was prepared (within twenty-four hours).
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Deionized or disti lied water was used in al) reagents, dialyses,
and assays.

The salt concentration never exceeded three parts per

mi 11 i on.
Equipment
The protein determinations were carried out using a Beckman DU
spectrophotometer and quartz cuvetts of one cm light path.

The in-

strument is a product of Beckman Instruments Inc., Fullerton, California.
Centrifugations were done in a Sorvall RC-2, automatic, refrigerated centrifuge manufactured by Ivan Sorvall, Inc., Norwalk, Conn.
This centrifuge is equipped with 4.25 inch (SS 34) and 5.75 inch (GSA)
raters.

Some of the centrifugations, when large volumes were involved,

were done in a Beckman L3-40 preparative ultracentrifuge, manufactured
by Beckman Instruments, Inc., Palo Alto, California.

It is equipped

with a type 15 rater (total capacity two liters).
The pH determinations for buffers were made with a Corning, Model
12, Research pH meter, at the temperature at which the buffer was to
be used.
Measurements of radioactivity in solution were made on a Unilux
model 6850 liquid scintillation system manufactured by Nuclear-Chicago
Corp., Des Plaines, Illinois.
The electrofocusing experiments were done on an LKB electrofocusing column, model 8101, 110 ml capacity.

An LKB Uvicord type 4701-A

ultraviolet analyzer, equipped with an LKB type 6520-A recorder was
used when an analysis of eluents from columns was desired.

Both in-

struments are products of LKB Instruments, Inc., Rockville, Maryland.
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Paper electrophoresis was performed with a Spinco model R paper
electrophoresis system, manufactured by Beckman Instruments, Inc.,
Fullerton, California.

A Beckman Duostat regulated power supply was

used for both paper electrophoresis and electrofocusing experiments.
Measurements of all volumes, 0.1 ml or less, were made using
appropriate sized Corning disposable micro pipets, purchased from
Corning Glass Co., Corning, New York.
Small volumes were evaporated to dryness in large test tubes
using a Rotary Evapo-mix from Buchler Instruments, Fort Lee, N. J.
Radioactivity on paper strips was detected by means of a Vanguard
Autoscanner 880; automatic chromatogram scanner manufactured by Vanguard Instrument Company, La Grange, Illinois.

EXPERIMENTAL PROCEDURE AND RESULTS
Before beginning the purification of an enzyme, it is desirable
to have a sensitive, specific, and preferably simple assay for the
detection of the enzymatic activity.

In the case of brain TPK, there

were several assays available which met the first two criteria, but
not the last one.

These were the enzymatic assays which utilize apo-

carboxylase (53 or 11) or apotransketolase (12,32).

Although neither

coupled enzyme assay was used in this study, a brief description of
each will be given.

The first mentioned system has been, by far, the

most popular, having been used, with several modifications, in almost
every TPK purification attempted to date.

The apocarboxylase used in

the assay was usually isolated from yeast.

The most common assay

consisted of incubation of the TPK with ATP, Mg++, and thiamin.

At

the end of the incubation, the reaction mixture was deproteinized
(usually by placing it in a boiling water bath) and the amount of
TOP synthesized was determined by adding apocarboxylase.
combined with apocarboxylase to form carboxylase.

The TOP re-

The activity of

the enzyme would be determined from the amount of CO 2 evolved with
pyruvate as a substrate.

The amount of co 2 was measured manometrically.

By adding known amounts of TOP to the apocarboxylase, standard curves
were prepared.

The volume of CO2 released from pyruvate could then be

directly related to the amount of TOP added.
The use of apotransketolase for TOP assay was developed in this
laboratory (12) for the purification of rat brain TPK.
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apotransketolase was isolated from yeast.

As in the case of the apo-

carboxylase assay, enzyme activity was calculated from the thiamin
diphosphate synthesized from thiamin as determined by the activation
of apotransketolase.

The transketolase activity was determined by a

coupled enzyme assay utilizing cornnercial preparation of triose phosphate isomerase and d..-glycerolphosphate dehydrogenase.

The coupled

system is illustrated by equations eight through twelve in Figure 1.
As can be seen from these equations, the transketolase activity could
be related to the oxidation of NADH (change in optical density at

340 mu).
Both of these assays suffer from the fact that they are coupled
enzymatic assays, and thus are susceptable to events which may influence the activity of the enzymes used for the assay.

For example, a

study of TPK inhibitors could be misleading if the inhibitors also
affected the enzymes used for the assay of TPK.

With proper precautions,

it is possible to use the coupled enzymatic assays in most situations.
However, the use of a more direct assay is desirable because it avoids
problems of the coupled assays.

The use of radioactively labeled

compounds was postulated as the means by which a more direct enzyme
assay could be developed.
Assay for Thiamin Pyrophosphokinase
The first idea tested was to use 32 P-labeled ATP.

The resulting

TOP would then be labeled by the transfer of the labeled phosphorous
atoms from ATP to thiamin.

The major insurmountable problem was to

separate the TOP produced by the reaction from the unused ATP.

This

was because of the large amount of ATP required in the assay, and the
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small amount of TOP produced.

The trailing radioactivity from the

ATP peak obscurred any radioactivity ascribable to TIJP.

As there

were relatively few methods published for the separation of the different adenosine sugar phosphates and the thiamin phosphates, no
method could be found which was sensitive enough to allow the complete
separation of ATP and TDP required by this type of assay.
Because of the above mentioned difficulties with the use of
labeled ATP, it was decided to use thiamin (thiazole-2- 14 c) hydrochloride as the source of radioactivity in the assay.

In addition,

in favor of the use of labeled thiamin, several methods for the separation of thiamin and its phosphate esters were available.

The first

attempted method used was to utilize a strong anion exchange resin
which would adsorb and retain the newly synthesized TDP while allowing the thiamin to pass through the column.

The use of this proce-

dure was hampered by the same troubles as the assay using ATP.

For

example; due to the large excess of thiamin as compared to the amount
of TIJP synthesized, the trailing radioactivity from the thiamin peak
completely obscurred the label on the synthesized TDP.

Sharma and

Quastel (33) and earlier Silliprandi and Silliprandi (64) had published
procedures for the separation of thiamin and its phosphate esters based on the use of a weak cation exchange column.

This type of column

adsorbs and retains the thiamin, and if in the right form, the thiamin
monophosphate, while the TDP is eluted in the water wash"

This seemed

to be the answer to the problem of trailing from the thiamin peak.
Therefore, it was decided to adopt the procedures of Sharma and Quastel

(33) for use as an assay for TPK.
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Preparation of ion exchange resin
The ion exchange resin, Amberlite CG 50, was prepared according
to the procedure of Sharma and Quastel (33) for the acid type resin.
Other brands of weak cation exchange resins (e.g. Rexyn 102, BioRex 70)
were used in the beginning of this work, but no differences could be
detected between the various resins employed.
would, therefore, appear to be immaterial.

The brand of resin used

The procedure used was as

follows:
The resin was stirred in water for twenty to thirty minutes and then
allowed to settle for about one to two hours.
was decanted,

The supernatant fluid

This procedure was repeated four or five times to com-

pletely remove the fine particles.

The resin was converted to the

sodium form by suspending in water and adding forty per cent NaOH until the pH of the suspension was at least eleven.
red at least three hours in the NaOH.

The resin was stir-

Following the removal of the

NaOH, it was washed several times by decantation with water.

The sod-

ium ion form of the resin was converted to the hydrogen ion form by
stirring the resin in a solution of 3N HCl for about four hours.

Fin-

ally the resin was washed, by decantation, with water until the pH of
the wash fluid was the same as the pH of the water being used.
resin was then stored covered with water.

The

The resin was used in this

form throughout the experiments reported in the following pages.
Measurement of radioactivity
Estimations of the radioactivity were made by taking one ml
aliquots of the column effluents and placing them in ten ml of scinti 1lation fluid.

This scintillation fluid was prepared according to the

procedure of Bray (65).

All samples were counted for at least ten
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minutes and the values given as cpm (counts per minute) are the average counts for the ten;ninute period.

Since some of the solutions were

cloudy after the addition of the effluent to the scintillation fluid,
the samples were checked for quenching.

This was accomplished by

adding a known amount of radioactivity to the samples and counting them.
The per cent quenching was calculated from the following equation:
Q

= ( 1 - I /s ) 1 00

( 13)

In the above equation Q = the per cent quenching, S = the cpm due to
the known amount of radioactivity under conditions where there was
minimal quenching, and I = the increase in cpm of the samples after
the addition of the known amount of radioactivity.

Although quenching

was found, it was about the same(~ 2%), for al 1 samples; so no corrections for quenching were made.

For use in the assays, the thiamin-

14c was diluted with carrier thiamin to give the final desired concentration of thiamin.

The specific radioactivity of each thiamin solu-

tion prepared was determined in the following manner:

A 0.10 ml ali-

quot of the assay blank was diluted to 10.0 ml with water.

After thor-

ough mixing, a 1.0 ml aliquot was withdrawn and counted for ten minutes.
Duplicate samples were run and the average cpm of the two was used to
calculate the specific radioactivity of the thiamin solution.

This

value, with the units of cpm/nmole, was used to calculate the nmoles of
TOP produced during the time of the assay.

It was assumed that the

specific radioactivity of TOP produced during the assay would be the
same as the specific radioactivity of the thiamin solution used,
Standard condition for enzyme assay
The reaction mixture for the assay of TPK was prepared so that
the concentrations of the reagent would conform to the optimum
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conditions of rat brain TPK, as given by Johnson (12,32).

The compo-

sition of the solution fSed is given in Table 2.
The assay solutions were incubated for one hour at 37°c, after
which 0.10 ml of fifty per cent trichloroacetic acid was added to
precipitate the protein.

If very much precipitate was present at

this time, the test tubes were centrifuged and then a O. 10 ml aliquot was removed and chromatographed on a 4 x 0,5 cm microcolumn of
the Amberlite CG 50,

The centrifugation step was eliminated if only

a little precipitate was present.

The column was eluted with three

ml of water, and the effluent was collected in a test tube.

After

thorough mixing, a one ml aliquot was withdrawn and the amount of
radioactivity present, was determined as outlined above.

The volume

of the remaining effluent was measured using a two ml serological
pi pet so the total cpm due to TOP in the 0. 10 ml of reaction mixture
could be found by multiplication of the cpm in the aliquot by the total volume of the effluent.
water in place of the enzyme.

For each assay, a blank was run by adding
The cpm, due to the blank, were sub-

tracted from the values for the enzyme-containing solutions.
Optimum column size for assay
The optimum size of ion exchange column was determined by trying
to find a length of column which would adsorb most of the cpm due to
thiamin, but which would allow the cpm due to TOP to be easily eluted.
The results of this study are given in Table 3.

As can be seen from

Table 3, the four cm column gives the best results
this was the size used in all assays.

For this reason

It should be noted that with the

thiamin-14c solutions used, there was always a considerable amount of
radioactivity eluted from the column, even when no enzyme was present.

TABLE 2
TiiE COMPOSITION OF STANDARD
ASSAY SOLUTION
Reaction componant (in order of addition)
0,5 M glycylglycine buffer, pH 7,8 at 37° which

Quantity
0.10 ml

is also 0.12 Min Mg

0.4 M ATP neutralized to pH 7.3

Final cone,
0,0556 M glycylgly~ine
0.0123 M Mg

0, 1 0 ml

O. 0444

0.10 ml

0.000222 M thiamin

M ATP

Water to make final volume equal to 0,90 ml
0.002 M thiamin- 14 c (about 300,000 cpm)

varying amounts of enzyme
volume during incubation equal to 0,90 ml

TABLE 3
DETERMINATION OF OPTIMUM COLUMN
LENGTI-l FOR TPK ASSAY
1 cm Column

2 cm Column

3 cm Column

4 cm Column

ml H20 added
to column

TDPb
alone

assay
sol 'n

TDP
alone

assay
sol' n

TDP
alone

assay
sol' n

1

27, 760a

1393

28,812

1089

8,538

940

98

2

6,248

663

4,765

341

26,097

441

3

340

667

337

261

755

4

113

346

132

223

34,461

3069

34,046

1914

Total cpm

% added

cpm

100

aA11 values are given as cpm

4.5

98,5

2.8

TDP
alone

assay
sol' n

344

67

66

30,205

854

20,688

1101

191

4,556

162

12,936

192

102

163

285

118

467

140

35,474

1735

35,144

1478

34,158

1499

103

2.6

TDP
a 1one

1 02

assay
so1 1 n

5 cm Column

2.2

bl 4c TDP was prepared from 14 c thiamin by the method of Viscontini et al. (66)

99

2.2
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Some of the thiamin- 14 c had to be purified before use.

This was done

by adsorbing 50 uCi of the radioactive thiamin on a microcolumn of
Amberlite CG 50, and eluting with large volumes of water (three to
five liters) to remove the radioactive impurity.
quired about a week.

This usually re-

The thiamin was then eluted with 0.1 N HCl,

evaporated to dryness, and redissolved in water to make the desired
volume of solution.

(Usually ten ml of 2 x 10-3 M thiamin solution

was prepared from fifty uCi of thiamin- 14 c.)
Validity of the TPK assay

The sensitivity of this assay depended upon the specific radioactivity of the thiamin solution used.

In the determinations of the

Km for thiamin, using a solution with a specific activity of 14.0
mCi/mmole (17,000 cpm/nmole found by actual measurement), it was possible to detect as little as two pmoles of TOP.

For the usual assays,

however, the lower limit of detection was about 0. 1 nmole of TOP
•
p 11cate
assays were accurate to w1. th"1n

+_

7°1

0,

Du-

In the assay, the cpm

found in the blank are proportional to the amount of thiamin- 14c added,

as shown in Figure 2.

The amount of TOP produced during the assay was

also shown to be linear with time.

Figure 3 shows, that at high con-

centrations of thiamin, as used in the regular assays, the amount of
TDP produced is linear with time for up to two hours.

Figure

4 shows

the linearity of the assay with a final concentration of thiamin of
only .022 uM.

As a further check on the validity of the TPK assay, it

was shown that the amount of TDP synthesized depended, in a linear manner, on the amount of protein added.
are given in Figure 5.

The results of this experiment
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Fig. 2.--Linearity of the cpm found in the assay blank
with the amount of added thiamin- 14 c. The solutions were prepared
as given in Table 2, except that the amount of thiamin was varied as
shown on the abscissa of the graph, The final volume was 1.00 ml
each case and no trichloroacetic acid was added.
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Fig. 3.--Linearity of the TPK reaction with time. Assay was
carried out by the standard method ( see ''Standard Condition for
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incubation was varied as shown.
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in Figure 2, except for the amount of thiamin used.
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In order to remove residual cont~mination of radioactivity, the
12 x 75 mm test tubes used in the assay were first washed in soapy
water; then, after rinsing, were soaked in the lN NaOH, which was followed by rinsing and soaking in lN HCl.
rinsed in distilled water.

Finally the test tubes were

After being cleaned by this procedure, test

tubes, which had contained the most highly radioactive solutions used,
had no detectable radioactivity.

Scintillation vials were also checked

by adding ten ml of the scintillation fluid and counting them before
use in the assay.

If any vial gave over fifty cpm for two successive

one minute counts, it was discarded.

All pipets which were to be re-

used, were soaked in sulfuric acid--sodium dichromate cleaning solution
or overnight in a 3N HCl solution to help remove any radioactivity.
Some time after the above assay was developed, Deus, et~- (57)
reported the development of another radiometric assay for TPK.

This

assay utilized paper chromatography or electrophoresis to separate TOP
and thiamin.

The authors state that:

For large-scale application the isolation of TPP by paper chromatography is less time consuming than by column chromatography or
by electrophoresis, because a great number of samples may be run
simultaneously.
It is not certain what a "large-scale application" consists ·of, but
for routine enzyme purification, the assay of Sharma and Quastel (33)
as outlined above, seemed simpler and easier than the assay of Deus,
et al.

For example, with the TPK assay as described above, about six

assays could be done in two hours.

In contrast, just the paper chroma-

tography step of Deus, et al. required twelve hours.
Units
The protein concentrations were determined by the method of
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Warburg and Christian

(67) using a Beckman DU Spectrophotometer.
I

Enzyme activity was expressed as nanomoles of substrate converted to
product per hour under the conditions of the assay.

This was related

to the cpm by the experimentally determined specific radioactivity of
the thiamin solution.
Products of the Reaction
Several unsuccessful attempts were made to identify TOP in eluates from the microcolumns used in the TPK assay.

The purpose of these

attempts was to show that the radioactivity being measured was due to
TOP, and not to radioactive thiamin.

The reason for the early fail-

ures was that the enzyme solutions were not active enough to be able to
produce sufficient TOP so it could be detected by other means.

How-

ever, as the purification progressed, a fraction from the alumina C
step was obtained which had a specific activity of seventy-two.

This

preparation was used to produce sufficient TOP so it could be detected
by electrophoresis.

At the end of the incubation, six microcolumns

were prepared and a 0.10 ml aliquot of the assay mixture was filtered
through each (see above).
ume of about twenty ml.

The effluents were combined, giving a volThe solution contained about 2000 cpm/ml.

The combined effluents were evaporated to dryness using a Rotary Evapomix with the bath temperature set at 35° and vacuum supplied by a water
aspirator.

The residue was taken up in one ml of water (0.10 ml of

this solution gave about 1100 cpm).

Using paper electrophoresis, the

solution was examined to see if any TOP could be detected.

The proce-

dure for electrophoresis was similar to that given by Silliprandi and
Silliprandi (64).

The electrophoresis was carried out in a Spinco mo-

del R system using 0.05 M acetate buffer, pH=

S.4 at room temperature.
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The electrophoresis run was done at room temperature for about three
and one half hours at a constant curr~nt of sixteen milliamps.

At

the end of this time, the paper strips were dried and the spots of
thiamin and it's esters were visualized by spraying with alkaline
ferricyanide reagent (64).

The spots of radioactivity were identi-

fied by running the paper strips through a Vanguard, Autoscanner 880,
automatic chromatogram scanner.

Two peaks of radioactivity were noted

in each strip which had been spotted with the concentrated effluent.
One peak corresponded to that of the radioactive impurity found in
samples of thiamin-

14

c,

and the other peak corresponded to authentic

samples of TDP- 14 c, Figure 6.

This experiment showed that the counts

of radioactivity in the effluent of the columns were due only to the
impurity from the thiamin and TDP produced.

The number of counts due

to the impurity from thiamin were found by running a blank for each assay, so that the counts over the blank value were due to the TDP produced by the TPK in the assay.
Thiamin Pyrophosphokinase Purification
In order to purify pig brain TPK, the procedure of Johnson (12,
32) for the purification of rat brain TPK was adapted as a guide.

The

procedure is essentially the same as that of Mano (55) for rat liver
TPK.

A systematic study of each step in the procedure was undertaken

so that the optimum conditions for the isolation of pig brain TPK could
be found.

The rsults of the study are as follows:

Acetone powder
In order to determine the efficiency of the acetone powder preparation and extraction, several attempts were made to determine the
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TPK activity in brain homogenates.

However, it was not possible to

detect any TPK activity in whole brain homogenates prepared as follows:
(rat brains were used in all these experiments.)
method 1)

The rat was sacrificed by decapitation and the brain

was removed, weighed and homogenized in three volumes of 0.05 M Tris
buffer, pH= 7.8.

The homogenate was centrifuged at 34,000 xg for

thirty minutes, and the supernatant solution was tested for TPK activity.

(In all of these experiments, TPK activity was determined by

the standard method outlined earlier, except that the volume of the
assay mixture was one ml.

Also there was no trichloroacetic acid added

after the incubation.)
method 2)

A rat brain was obtained as in method 1 and was homo-

genized in ten volumes of 0.05 M Tris, pH 7.8.

The homogenate was

then sonicated with a Branson sonic oscillator for a total of three
minutes at 130 watts of power.

The sonication was accomplished in six

thirty-second intervals with about three minutes rest between each sonication.

The sonication was carried out in an ice-salt bath; and dur-

ing the resting period, the homogenate was kept in an ice bath to allow the solution to cool at

o0 •

The extract was then centrifuged at

2,000 xg to remove cellular debris.

The precipitate was discarded and

the supernatant solution was recentrifuged at 34,000 xg for twenty minutes.

The new supernatant solution was decanted and assayed for TPK

activity.

The precipitate was resuspended in a 0.05 M Tris, pH= 7.8,

and assayed for TPK.
method 3)

A rat brain was obtained as in method one and was hom-

ogenized in five volumes of 0.05 M Tris, pH= 7.8.
centrifuged at 1,000 xg for twenty minutes.

The homogenate was

The precipitate was
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discarded and the supernatant fraction was assayed for TPK.

It was

felt that perhaps the reason for the lack of TPK activity in the whole
brain homogenates was the presence of a TDPase in them.

Therefore the

supernatant solution prepared, as in method three, was assayed for
TDPase activity.

The assay was exactly the same as the TPK assay,

except that thiamin and ATP were left out and 3.63 umoles of TOP-

14

c,

prepared from thiamin- 14c according to the method of Viscontini et al.

(66), was added.

It was found that the homogenate could hydrolze 0,303

umoles of TOP per hour under the conditions of the assay.

This is

more than enough TOPase activity to completely hydrolyze any TOP produced in the TPK reaction.

It was felt that perhaps the TOPase could

be inhibited without affecting the TPK reaction, thus allowing the
study of TPK activity in whole brain homogenates.

Naidoo and Pratt (68)

reported that lanthanun nitrate, at a concentration of 7,7 x 10-5 M,
causes about fifty per cent inhibition of rat brain TOPase.

The as-

says of TPK and TDPase were, therefore, run with lanthanun nitrate
added to give a final concentration of 1 x 10- 4 M.

Under these con-

ditions the TOPase activity showed about sixty-five per cent inhibition, but again no TPK activity could be detected.

The lack of TPK

activity was probably due to the fact that remaining TOPase activity
was sufficient to hydrolyze all TOP produced.
Since no TPK activity could be detected in whole brain homogenates, several ways of preparing acetone powder were studied to see if
the manner of preparation of the acetone powder affected the amount of
the TPK extractable from it.
pare pig brain acetone powder:

The following methods were used to pre-
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method 1)

Fifty grams of brain were homogenized for fifteen

seconds at high speed in a Waring blender with 500 ml (ten volumes)
of acetone.

The acetone was cooled to -20° before use.

The homogen-

ate was filtered by suction and the filter cake was rehomogenized
three more times using the same technique.

After the last filtration,

the filter cake was powdered with a spatula, and the acetone was removed by evaporation in a hood at room temperature.
method 2)

Fifty grams of pig brain was homogenized for fifteen

seconds, at high speed in a Waring blender, in 500 ml of acetone cooled to

o0 before use.

The acetone was removed by suction filtration

and the homogenization was repeated.

The filter cake from the second

filtration was homogenized for one minute, at low speed, in 500 ml of
n-butanol, cooled to -20° before use.

The homogenate was stirred in

the cold room for twenty minutes and the butanol was removed by suction filtration.

The filter cake was extracted with n-butanol in the

same manner as before.

This was followed by extraction with two more

500 ml portions of acetone following the same procedure used in the
beginning.

The acetone was removed from the final fi 1ter cake by

powdering it in a hood and allowing the acetone to evaporate.
method 3)

The procedure here is exactly the same as that given

in method 1, except that after the first filtration, two filter cakes
were combined and carried through the rest of the procedure.

This

change was instituted so that the amount of acetone used, and the
time required to process large numbers of pig brains, would be cut
by a considerable amount.

No differences between the amount of act-

ivity extractable from this acetone powder and that prepared by method one could be detected.
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Using method one, 0.2 gm of acetone powder was obtained for
each gram of brain.

Using method two, only 0.15 gm of acetone pow-

der per gram of brain was obtained.

As can be seen from Table 4, the

units of TPK activity per gram of acetone powder are higher with powder prepared by method two.

However, the activity per gram of brain

is generally higher with acetone powder prepared by method one.

For

this reason, and because method two was much more time consuming, it
was decided to utilize method one to prepare the acetone powder.

(in

later preparations method three was used, but no difference in the
units of TPK extracted per gram of acetone powder could be detected.)
Once prepared and freed of acetone, the powder was stored 1n a
vacuum dessicator over P205.
at Oto 5°.

The dessicator was kept in a cold room

The acetone powder could be stored in this state for at

least a year without any loss of activity.
Extraction of acetone powder
A standard procedure for the extraction of the acetone powder
was adopted as follows:
The amount of acetone powder to be extracted was suspended in ten
volumes of the buffer being used, and was slowly stirred to completely wet the powder.

(For best results, when more than five grams of

acetone powder were being processed, this mixture was stirred for at
least five hours.)

The solution was homogenized for five minutes

using a teflon-glass homogenizer.

If all the solution could not be

homogenizer at once, aliquots were removed, and each was homogenized
for five minutes.
at 34,800 xg.

The homogenate was centrifuged for twenty minutes

The supernatant solution was decanted and the precipi-

tate was re-extracted with four volumes of buffer by homogenizing

TABLE 4
COMPARISON OF TI-lE TPK ACTIVITYa EXTRACTED FROM PIG BRAIN ACETONE POWDER
PREPARED BY BOTI-l METI-lOD 1 AND 2 BY VARIOUS BUFFERS
Method 1 Acetone Powder
Type of buffer

Method 2 Acetone Powder

Units of activity
gm acetone powder

Units of activity
gm of brain

0.05 M glygly
pH= 7.8

73.7

14.9

113 .9

17.0

0. 02 M g 1yg 1y
pH= 7.8

95 .8

19.4

114. 2

17. 0

Units of activity
gm acetone powder

Units of activity
gm of brain

0.02 M pyrophosphate
pH = 7.0

85.7

17.3

129 .2

19.4

0.02 M pyrophosphate
pH= 8.0

115. 0

23 . 2

116. 3

17. 3

0.02 M pyrophosphate
pH = 9. 0

77.4

15.6

101 .8

15. 2

0.05 M Tris
pH = 7.8

94.6

19.2

109. 5

16.4

M NaCl

112,9

22.8

146.0

21.8

o. 15

aln the above experiments the TPK activity was determined by the standard method (see 11 Standard
Condition for Enzyme Assay"), except that the volume of the solution incubated was one ml and, after
the incubation, no trichloroacetic acid was needed. Instead, the assay mixtures were placed in a boiling water bath for eight minutes, to denature the protein.

V,
V,

for a period of two minutes.

The homogenate was again centrifuged at

34,800 xg for twenty minutes and the supernatant solution was conbined
with the previous one.

The precipitate was now discarded, and the

combined supernatant solutions used for further purification of TPK.
A study was made to determine the optimum conditions of pH,
ionic strength, and buffer type for the extraction of TPK from the
acetone powder.

Acetone powder prepared by both method one and method

two was used in the study in order to determine which method would
give the best results.

The assays were done at least in duplicate

and the results, given in Table 4, are the averages of the assays.
For extracting the TPK activity from the acetone powder 0.15 M
NaCl was selected as the best solution to use.

This solution extracts

more TPK activity from acetone prepared by method two than any other
solution tested (Table

4).

Also within the limits of experimental er-

ror, the amount of activity extracted from acetone powder prepared
by method one was as great as that extracted by any other solution
used (see Table

4).

Another advantage was that the NaCl solution was

very simple to prepare.
Protamine sulfate treatment
It was felt that removing the nucleic acids would improve the
remainder of the purification scheme.

It was later found that the pro-

tamine sulfate treatment affects only one other step of the purification; the acid treatment step.

A much higher yield of protein is ob-

tained in this step if the protamine sulfate step is included.
At first it was felt that the TPK activity could be fractionated
with the protamine sulfate.

In order to accomplish this, a one per
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cent protamine sulfate solution was prepared and the pH was adjusted
to about seven with NaOH.

The solution of protamine sulfate was then

added to the extract until a total of two ml of protamine sulfate per
one hundred ml of extract had been added.

The solution was stirred

for fifteen minutes and then centrifuged at 37,000 xg for fifteen minutes.

The supernatant solution was decanted and more protamine sul-

fate solution was added until a total of ten ml of protamine sulfate
per one hundred ml of extract had been added.
stirred and centrifuged as before.

The solution was then

The supernatant fraction was de-

canted and both precipitates were resuspended in a 2:1 mixture of
water and 0.5 M glycylglycine buffer, pH equal to

7.8.

All three

fractions were assayed for TPK activity using the standard assay procedure.

TPK activity was found only in the supernatant fraction.

The

specific activity of the TPK was increased during this step and, in
addition, the total amount of TPK activity was increased.

The latter

observation was probably due to the removal of some TPK inhibitor by
the protamine sulfate treatment.
same results being observed.

The experiment was repeated with the

Therefore, for routine use in the purifi-

cation scheme, a quantity of the neutralized one per cent protamine
sulfate was added to give a final concentration of ten ml protamine
sulfate per one hundred ml of extract.

The solution was stirred to ob-

tain equilibrium and was finally centrifuged as described above.

The

precipitate was discarded and the supernatant solution was saved for
the next step.
The heat treatment
Both Mano (55) and Johnson (32) used a heat treatment step which
consisted of lowering the pH of the acetone powder extract to 5.8 by

slowly adding 0,5 N acetic acid.
minutes in a 52° water bath.

The extract was then heated for five

Then the enzyme was cooled in an ice

bath and the precipitate formed was spun down and discarded.

With

both rat liver and rat brain enzyme preparations, a four or five-fold
purification was observed--many times with an increase in total activity.

This was not observed with the pig brain enzyme.

Under the

above conditions, only a two, or sometimes three-fold purification
would result and, even then, only sixty or seventy per cent of the
total activity was recoverable.

In an attempt to obtain better yields

from this step, the effects of changing temperature, time, and pH of
the incubation were studied.

In these studies the extract of the ace-

tone powder was used which had not been treated with protamine sulfate.
In Figure

7 the relationship between the pH of the extract during the

heat treatment and the activity is shown.

The pH of the aliquot of the

extract was adjusted to the desired value and it was incubated in a
52° water bath for five minutes.

Then, after cooling to o0 and cen-

trifugation, an aliquot of the supernatant solution was assayed for
TPK activity by the standard procedure.

This experiment was repeated

several times and the results indicated that the pH which gave the
best combination of increase in specific activity and recovery of total
activity was 5.8.

From the results shown in Figure 7, it was difficult

to tel 1 whether the optimum pH for the heat treatment was 5,4 or 5.8.
The optimum temperature for the heat treatment step was determined
by heating aliquots of an acetone powder extract, whose pH had been adjusted to 5.8, in water baths at temperatures from 37° to 60°, for five
minutes.

Then after cooling and centrifugation, aliquots were removed

and assayed for TPK activity by the standard procedure.

Figure 8
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shows the results of one such study.

As can be seen, the temperature

which resulted in the greatest recovery of total activity, as well as
the largest increase in specific activity is 52°.
The optimum time for the heat treatment step was determined by
adjusting the pH of an acetone powder extract to 5.8 with 0,5 N acetic
acid and heating aliquots of the solution in a 52° water bath for various lengths of time.
given in Figure 9,

The results of an experiment of this type are

Several experiments of this type were run and, as

can be seen from Figure 9, the length of time the enzyme solution was
heated in the 52° water bath at pH 5,8 was not critical.

For this

reason, the time of five minutes was chosen for this treatment.
After all the experiments, it was concluded that the original
conditions of heating the extract at 52° for five minutes with the
pH adjusted to 5,8 gave the best combination of increase in specific
activity and per cent recovery of activity.

Therefore these conditions

were adopted for use in the standard scheme for purification.

The most

critical factor to control during the treatment was the temperature.
If it was controlled, the pH and length of time of the treatment could
be varied over a fairly wide range (see Figures 7, 8, and 9).
Ammonium sulfate fractionation
A study was made to determine the optimum conditions for ammonium sulfate fractionation of the TPK.

This study was carried out us-

ing acetone powder prepared by method one from beef brain.

The ace-

tone powder was extracted with 0.05 M glygly, pH= 7.8; and the heat
treatment was carried out by the standard procedures given above.

The

procedure used for carrying out the am~onium sulfate fractionation is
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as follows:

An amount of ammonium sulfate necessary to give the desired

per cent saturation was slowly added to the enzyme solution at 0° with
constant stirring.

After all the added ammonium sulfate was dissolved,

the mixture was allowed to stand for twenty minutes and any precipitate
was then removed by centrifugation at 10,000 xg for twenty minutes.
The protein pellet from the centrifugation was redissolved in 0.25 M
glygly buffer, pH 7.8.

Each precipitate was checked for total pro-

tein and TPK activity.

The results of this study are given in Figure

10.

As can be seen, there is very little TPK activity precipitated

below fifty per cent saturation, and most TPK activity is precipitated
at seventy per cent saturation.

Therefore the protein precipitating

between fifty and seventy per cent saturation was saved and used in the
standard protein purification.

A similar, though less detailed, study

using pig brain acetone powder showed that most of the enzyme activity
was recovered when the protein precipitating between fifty and seventy
per cent saturation was saved.

Table 5 shows the results of one such

study.
Desalting
In order to remove the ammonium sulfate salt, Mano (55) used a
dialysis step, but he didn't check to see if there was any loss of
activity during the dialysis.

Johnson (32) reported that rat brain

TPK lost activity during dialysis against water.

During the purifica-

tion of pig brain TPK, the loss of activity during dialysis was repeatedly observed.

Several techniques were used to try to avoid the loss

of activity during dialysis.

The TPK was dialyzed against several dif-

ferent buffers, as well as water, but the loss of activity sti 11 occurred.

Addition of thiamin (2 x 10- 3 M) or ATP (10 -J M) and Mg++ (10- 3 M)
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TABLE 5
PRECIPITATION OF PIG BRAIN TPK
BY AMMONIUM SULFATE
Fraction

0

- 5 0"/4 s a t . ppt.

Total protein

89 mg

Specific activitya

0.14

Total activity
12.8

% yield
12.6

°'

V,

50 - 70"/o sat. ppt.

28 mg

2.51

71. 2

70. 0

70"/o sat. supernatant

33 mg

0. 10

3.3

3.0

aThe enzyme was assayed by the standard procedure (see assay procedure section).
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in combination did not protect the TPK during dialysis.

Because of

the loss of activity during dialysis, other means for removing excess
ammonium sulfate were sought.
filtration.

The best method was found to be gel

Using Sephadex G-200 columns and eluting with 0.15 M NaCl,

the activity could almost be completely recovered with an increase in
specific activity.

The only problem with the procedure was that it

required twenty-four to forty-eight hours for completion.

It was then

found that, when a column of coarse grade Sephadex G-25 was used, the
protein and the ammonium sulfate could be completely separated in only
two to three hours.

When the elution with a dilute buffer (.005 M

glygly, pH= 7.4), the separation was accomplished by a slight loss
of activity--but no loss of protein.

Because of the ease and speed of

this procedure, the Sephadex G-25 column was used for desalting during regular TPK purification.
Acid treatment
Mano (55) reported a two-fold increase in the specific activity
of rat liver TPK following an acid treatment step which consisted of
lowering the pH of the dialysate to 4.3 with acetic acid and incubating
at 370 for thirty minutes, followed by cooling and centrifugation.
Using a similar procedure, Johnson and Gubler (12) reported a slight
increase in specific activity during the purification of rat brain TPK.
Acid treatment according to the procedure of Mano as described above,
consistently caused considerable loss of activity as well as a drop in
the specific activity.

However, the loss in activity during this step

was held to a minimum by keeping the solution at o0 and by previous
treatment with protamine sulfate.

When the TPK preparation had not

been fractionated with protamine sulfate prior to the acid treatment,
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this treatment was accompanied by the formation of a relatively large
amount of precipitate with a concurrent drop in specific activity and
loss of total activity.

After including the protamine sulfate fract-

ionation, very little precipitate was formed during the acid treatment.
A drop in specific activity was still observed, but the loss in total
activity was cut to a minimum.
It should be noted that many attempts were made to bypass the
desalting and acid treatment steps and go directly to the alumina CY gel fractionation; but these all failed.

If the desalting and acid

treatment were included, an increase in specific activity was obtained
after alumina CY-gel fractionation.

However, if either or both of

these steps were eliminated, it was not possible to obtain any purification using the alumina C ~-gel.

Therefore, it was felt that it would

be profitable to continue to include the desalting and acid treatment,
even though no purification resulted from these steps per se.
Alumina Cl(-gel fractionation
The further purification of pig brain TPK using a column made up
from a mixture of alumina C¥-gel and hyflo Super-eel filter aid was
attempted.

The procedure used, and the type of column were essentially

the same as those outlined by Mano (55) for the purification of rat liver TPK.

It was not possible, however, to obtain consistent results

using an alumina C ~-gel column.

The alumina C'2f-gel columns would,

in most cases, plug up even though they were prepared with large excesses of the hyflo Super-eel.

At other times, when good flow rates were

achieved, little or no purification of the TPK resulted.

Because of

these and other difficulties with the use of alumina C}'-gel columns,
a fractional adsorption procedure was adopted.
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Alumina

c0

-gel prepared by Willstatter 1 s method, as reported

by Colowick (69), was used for all these experiments.

The gel had

been prepared about four years previous to its use.
For the fractionation study, a volume of the gel containing
enough alumina C?( to give a gel to protein ratio of two (W:W) was
removed and divided into six aliquots.

The TPK activity was adsorbed

by stirring an aliquot of the gel and the protein solution for twenty
minutes at 0°.

The gel was then removed by centrifugation at 34,000

xg for ten minutes.
gel.

The process was repeated with each aliquot of

It was found, after treatment of the protein solution with the

second aliquot of gel (each gel aliquot was such that the ratio of
the weight of the gel to the weight of protein present originally was
equal to 0.33) that all the TPK activity was adsorbed.

To elute the

TPK activity from each aliquot of the gel the following procedure was
adopted:

The gel was suspended in the desired buffer and was stir.red

for twenty minutes, after which it was removed by centrifugation for
ten minutes at 34,000 xg.

The solutions used for elution were 0.1 M

in NaH2P04 with the pH adjusted (with lN Na0H) to equal 4.4, 5, 1, 5.6,
and 6.2 respectively.

The gel aliquots were washed following the a-

bove procedure using the 0. 1 M phosphate solutions in the order of increasing pH.

Most of the TPK activity adsorbed by the first gel ali-

quot was eluted by the first two washings, whereas most of the TPK
activity adsorbed by the second gel aliquot was eluted by the second
and third washings.

TPK of the highest specific activity was usually

obtained in the third washing of the second aliquot of gel.

The pro-

tein from each of the gel washings was precipitated by adding powdered
ammonium sulfate to get eighty-five per cent saturation.

The precipitate

was collected by centrifugation at 12,000 xg for twenty minutes, and
it was redissolved in 0.25 M glycylglycine buffer, pH 7.8.
activity in each fraction was then determined.
mina C¥-gel fractionation are given in Table 6.

The TPK

The results of the aluAs can be seen from

the table, one fraction (usually the third wash from the second gel
fraction) has a relatively high specific activity compared to the other fractions.

Unfortunately the amount of protein in this fraction

was so small, that by itself, it could not be purified any further.
Sephadex G-100 chromatography
Those fractions from the alumina C¥-ge1 treatment which contained most of the TPK activity were combined and filtered through either
a 2.5 x 40 cm or a 1.5 x 30 cm Sephadex G-100 column, depending on the
volume of solution to be used.
M glygly, pH=

The TPK activity was eluted with 0.005

7.4. A single peak containing TPK activity was found

and it was used immediately in the next step.
Isoelectric focusing
The final step in the purification scheme was isoelectric focusing carried out using an LKB model 8101 electrofocusing apparatus.
This procedure depends on the fact that ampholytes, such as proteins,
if placed in a stable pH gradient, will migrate to a point where they
are electrically neutral when a current is applied across the gradient.
The pH of the fraction where the protein is found is equal to its isoionic point, or pl.

In the case of the LKB electrofocusing apparatus,

the pH gradient is formed from a mixture of low molecular weight ampholytes.

The ampholytes are a mixture of aliphatic polyamino poly-

carboxylic acids.

When a direct current is applied to this mixture,
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TABLE 6
PURIFICATION OF TPK WITH
ALUMINA C
-GEL

o

Fractiona

Specific activity

% recovery

Total activity

Starting material
(from acid treatment;

1.34

1, 139

100

First supernatant
fraction

1.26

899

---

First gel fraction
pH 4.4 eluate
pH 5. 1 eluate
pH 5.6 eluate
pH 6.2 eluate
Second gel fraction
pH 4.4 eluate
pH 5. 1 eluate
pH 5.6 eluate
pH 6.2 eluate

---

NO ACTIVITY

Second supernatant
fraction

4.30
8.2
7.7
2. 1
4.0
17. 1
46.2
12.6

44.3
36.6
33.3
22.7

4
3
3
2

32.9
65.7
160.2
232. 1

3
6
14
20
-

aDetails on preparation of the fractions are given in the text.
Enzyme assayed by the standard procedure (see "Standard Conditions
for Enzyme Assay").
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the ampholyte molecules are sorted out according to their respective
p! 1 s, thus forming a continuous pH gradient over the range of p! 1 s
present in the ampholine mixture, the pH in any part of the column,
at equilibrium, being equal to the p! of the amplholine molecules concentrated at that spot,

The pH gradient is stabilized against con-

vection by forming it in a sucrose density gradient.

The column is

also thermostated to prevent heat build-up and to allow electrofocusing runs to be made at any desired temperature between 0 and 40°.

For

the isolation of TPK, all the electrofocusing experiments were done at
a temperature of three degrees.

A preliminary experiment was done with

a solution of wide range ampholine, pH 3 to 10.

This established that

the p! of the TPK was in the acid range, between three and five; therefore, subsequent electrofocusing runs were done with narrow range ampholine solutions.
to six.

The pH range used was either three to five or three

The procedure for an electrofocusing experiment is as follows:

First the solutions for filling the column were prepared as directed (70) with the anode at t he bottom of the column.

Phosphoric acid

was used in preparing the solut i on at the anode and ethylenediamine
was used in preparing the solut i on at the cathode.
mixed with the

11

The enzyme was

light 11 solution to give the desired volume.

umn was loaded using a pump and an LKB gradient mixer.
rate was four ml per minute or l ess.

The col-

The filling

The current was applied and the

electrofocusing was continued unt il the current, at constant voltage,
decreased to a constant value.

This required twenty-four to seventy-

two hours, depending on the pH r ange of the ampholine mixture.

At the

end of the run, the column was unloaded, as directed (70), with the
flow rate being adjusted so that it was less than one ml per minute.
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Fractions were collected at five minute intervals and the pH of each
fraction was then determined using a Corning Model 12 pH meter equipped
with a combination electrode.

The fractions whose pH, when collected,

was between 3.7 and 4.5 were adjusted with NaOH to a pH between 7 and
8.

The optical density at both 280 and 260 mu was determined and those

fractions with the peak adsorption at 280 mu were assayed for TPK activity by the standard method.

The highest specific activity was us-

ually found in tubes with a pH between

4 and 4.3.

The fractions containing TPK activity were then treated in several different ways.

Some were used directly in experiments to de-

termine some of the properties of the enzyme.

If kept in the sucrose

solutions at a pH between seven and eight, the enzyme activity was
most stable.

Other treatmen ts, described below, caused a drop in act-

ivity of as much as fifty per cent in twenty-four hours.

Sometimes

the enzyme was freed from the sucrose and ampholine by filtering each
fraction through a Sephadex G-25 column.

The fractions from the G-25

column could then be used directly in the experiments or the protein
could be precipitated by adding ammonium sulfate.

In other experiments,

the enzyme in fractions from the electrofocusing columns was freed of
sucrose and ampholine by diluting each fraction with about three volumes
of water and precipitating the protein with ammonium sulfate.

The

precipitate was resuspended in glycylglycine buffer for use in the experiments.

For some experiments, such as the ultracentrifuge analysis,

the resuspended ammonium sulfate precipitate was dialyzed against .013
M glycylglycine buffer to remove the ammonium sulfate.
To summarize the experiments described above, the method of purification which gave the best results is described below and consists
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of the following ten steps:
Step 1.

Preparation of acetone powder.--The brains were removed

from the animals as soon as possible after death, and were placed on
ice for transport to the laboratory.

After washing to remove blood

clots and bone chips, fifty gm portions of the brains were homogenized
in five hundred ml of acetone, pre-cooled to -20°, for fifteen seconds
at high speed in a Waring blender.

The acetone was removed by suction

filtration, and the filter cake was homogenized three more times following the same procedure.

(After the first homogenization, two filter

cakes could be combined and carried through the rest of the procedure.)
The acetone was removed from the final filter cake by powdering it in
a hood at room temperature.

The acetone powder was stored in a dessi-

cator over P205 at Oto 5°.

In this form it could be stored without

loss of activity for about one year.
Step 2.

Extraction.--The acetone powder was extracted with

fourteen volumes of 0. 15 M NaCl.

First the powder was stirred for a

minimum for three hours in ten volumes of the salt solution.

Then,

using a Potter-Elvehjem teflon-glass type homogenizer, aliquots were
homogenized for five minutes each.
34,800 xg for twenty minutes.

The homogenate was centrifuged at

The supernatant fraction was saved and

the packed precipitate was rehomogenized in the remaining four volumes
of the salt solution.

The homogenate was centrifuged, as before, and

the second supernatant solution was combined with the first and the
combined supernatant solutions were used in the next step.
Step 3,

Protamine sulfate treatment.--Ten ml of one per cent

protamine sulfate solution (pH approximately seven to eight) per one
hundred ml of extract was slowly added with constant stirring.

The
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stirring was continued for twenty minutes after the last of the protamine sulfate had been added and the precipitate was then removed
by centrifugation at 34,800 xg for fifteen minutes.
Step 4.

Heat treatment.--The pH of the supernatant solution

from the previous step was lowered to 5.8 by slowly adding 0,5 M acetic
acid with continuous stirring.

The clear solution was distributed in

15 x 150 mm test tubes and the tubes were incubated in a 52° water bath
for five minutes.

The enzme solution was cooled in an ice bath im-

mediately after the treatment and the precipitate formed was removed
by centrifugation at 15,000 xg for twenty minutes.
Step 5,

Ammonium sulfate fractionation.--To the supernatant

solution from the heat treatment step, solid ammonium sulfate, which
was pulverized in advance, was slowly added to give 0.50 saturation
(31 .35 gm per one hundred ml volume).

After standing about twenty

minutes, the precipitate was removed by centrifugation at 10,800 xg
for twenty minutes and discarded.

To the resulting supernatant sol-

ution, more solid ammonium sulfate was added, as above, to give 0.70
saturation (an additional 13.49 gm for every one hundred ml volume resulting from the first ammonium sulfate addition).

After standing

for about twenty minutes, the solution was centrifuged as before, and
the precipitate was saved and the supernatant was discarded.

The pre-

cipitate was resuspended in a smal 1 amount of glycylglycine buffer, pH

= 7.8.

In this state the TPK activity was quite stable, losing almost

no activity when stored at Oto 5° for up to two weeks.
Step 6.

Desalting.--Excess ammonium sulfate was removed from the

resuspended precipitate from step five by filtering it through a 2.5
x 40 cm column of Sephadex G-25 (coarse grade).

The protein was
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eluted with 0.005 M glycylglycine buffer, pH= 7.3.

The eluate (sixty

to eighty ml) containing most of the protein, was used immediately in
the next step.
Step

7. Acid treatment.--The pH of the eluate from step six was

lowered to 4.3 by slowly adding 0.5 M acetic acid with continuous stirring, and 0.02 volume of 0.5 M acetate buffer, pH= 4.3 was added.
solution was allowed to stand at Oto 5° overnight.

The

The small amount

of precipitate formed was removed by centrifugation at 10,800 xg for
twenty minutes.
Step 8.

Fractional adsorption by alumina C(l"-gel.--The TPK act-

ivity was adsorbed from the supernatant solution from the acid treatment (step seven) by adding enough alumina C'l{-gel to give a gel to
protein ratio of 0.33.

After stirring for twenty minutes, the gel was

removed by centrifugation at 34,800 xg for ten minutes.

The resulting

supernatant solution was treated with another equal portion of the gel
using the procedure as outlined above.

If necessary, the solution

obtained from the acid treatment was diluted with water to give a
protein concentration of ten mg per ml or less, before beginning the
alumina Cl( adsorption.

To avoid further dilution of the protein sol-

ution, the gel could be precipitated before use by centrifugation at
34,800 xg for ten minutes.

The precipitated gel was then resuspended

in the protein solution.
In order to elute the TPK activity from the alumina C(( -gel,
each fraction was treated as follows:
solvent and stirred for twenty minutes.

The gel was suspended in the
The gel was then precipitated

by centrifugation at 34,800 xg for ten minutes.
order of use were as follows:

The solvents and their

All were 0.1 Min NaH 2 P04; their pH's
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were adjusted to 4.4, 5.1, 5.6, and 6.1 respectively.

The amount of

each solvent used was dependent on the amount of gel, but was approximately ten ~1 per one hundred mg of gel.

From each alumina Cc( -gel

fractionation procedure performed, eight fractions were obtained, four
for each portion of gel used.

The protein in each of the eight frac-

tions was precipitated by slowly adding powdered ammonium sulfate to
0.85 saturation (0.608 gm per ml of solution).

The precipitates were

each resuspended in small amounts of 0.25 M glycylglycine, pH=
and assayed for TPK activity.

7.8

The most active fractions were pooled

and used in the next step.
Step 9.

Sephadex G-100 chromatography.--The combined alumina

C~ fractions were filtered through a 2.5 x 40 cm column of Sephadex
G-100.

The protein was eluted with 0.005 M glycylglycine, pH=

7.4.

The peak of TPK activity was collected in a volume of about fifty ml.
The purpose of this step was to obtain an ionic strength low enough
to enable the carrying out of the next step, electrofocusing, and to
get an increase in specific activity.

Both purposes were accomplished ,

but about half the protein was lost during the procedure.
Step 10.

Electrofocusing.--The fractions from the G-100 column

which contained most of the TPK activity were combined and placed in
an electrofocusing column.

The procedure used in this step is exactly

the same as described earlier.

Therefore it will not be repeated here.

The process of purification is summarized in Table 7.
Properties of the Enzyme
In all the determinations involving measurement of the properties of pig brain TPK, enzyme from step ten was used except where noted .
Enzyme from several different preparations was used in the following

TABLE 7
PURIFICATION OF PIG BRAIN THIAMIN
PYROPHOSPHOKINASE
Fraction

Volume

Step 1
Step 2
Step 3
Step 4
Step 5
Step 6
Step 7
Step 8
Step 9
Step 10
F. 13
( pH = 3. 9)
F. 14
( pH = 4.4)

f cQ ..,
\~- • I

560.
594.
574.
33.
68.
71.
9.2
50.5

gm)

Total
protein
(mg)

Specific

Total
activity
(units)

-------

-----

------

8,192.
5,061 •
2,569.
948.6
887.4
850. 3
47.7
25. 1

activitya
units/mg
0.38
o. 56
0.72
1.54
1 .45
1.34
7.8
9.8

3, 121
2,859
1,837
1,495
1,289
1,139
372
247

% yield

-----

100.
92.b
59.
47.
41.
37.
11.9
7.9

Over a 11
purification

---------

1.5
1.9
4.0
3.8
3.5
20. 5
25.8

4.7

1.5

40.0

60.8

1.9

105.

4,7

1 .4

98,9

141. 4

4. 5

260.

arhe enzyme was assayed according to the standard procedure as given in Table 2 and the procedure section.
bin this case an increase ,n total activity was not observed.

--J
--J

experiments.
The pH optimum for pig brain thiamin pyrophosphokinase
The pH optimum for the purified TPK was determined using a mixed
phosphate-glycylglycine buffer system.

This system was chosen to pro-

vide good buffering capacity over a pH range of about six to nine.
A combination of buffers was used instead of two separate buffers to
insure that any effect of the buffer on the enzymes would be reflected
at each pH to be considered.

A solution was prepared which was 0.25

M with respect to phosphate and 0.25 M with respect to glycylglycine
and 0.5 M overall to correspond with the buffer used in the standard
assay (see Table 2).

Aliquots of the buffer were removed and adjusted

to the desi~ed pH with either concentrated HCl or NaOH.

These buffers

were used in the standard assay system (see Table 2 and procedure section), except that only 0.05 ml of the ATP solution was used.

After

several trials, it was found that the addition of the ATP solution was
causing changes in the pH of some of the buffers, even though the ATP
was neutralized to pH

7. 4 before use.

For example, after the addition

of ATP, the reaction mixture at pH 9.3 was found to have a pH of 8.2.
Therefore, for the experiment reported in Figure 11, the pH of each
assay was checked after the addition of ATP and, if necessary, the pH
was adjusted to the desired value.

Each pH was determined at 37° us-

ing a Corning Model 12 pH meter equipped with a combination electrode.
As can be seen from Figure 11, the optimum pH for purified pig brain
TPK is rather broad, extending from about 8.3 to 9.3 in the phosphate
glycylglycine buffer system.
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Fig. 11.--pH optimum for pig brain TPK in glycylglycine
phosphate buffer (0.25 Min each componant). The pH of each reaction
mixture was determined experimentally. The enzyme assay was the same
as the standard assay (See ''Standard Condi ti on for Enzyme Assay") except that only 0.05 ml of ATP was added.
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Optimum magnesium concentration for pig brain TPK
The optimum magnesium concentration for the purified enzyme was
determined by using the standard assay system, except only 0.05 ml of
ATP was used and the amount of magnesium added was varied.
sults of this study are given in Figure 12.

The re-

As can be seen, there was

an optimum amount of magnesium for the purified TPK.
of this optimum, the activity fell quite rapidly.

On either side

Figure 13 shows the

results of an experiment during which the ATP concentration was varied,
while the amount of magnesium was held constant.

This experiment

shows that the shape of the curve when the (Mg++)/(ATP) ratio was
plotted versus amount of TOP synthesized was exactly the same as the
curve obtained when {Mg++) is plotted versus amount of TOP synthesized.
Kinetics
The kinetics of the purified thiamin pyrophosphokinase were studied in an attempt to gain more understanding of the mechanism of the
enzyme.

At first it was assumed that simple Michaelis-Menton kinetics

would be followed.

Figure 14 gives a double reciprocal plot of TOP

synthesis versus ATP concentration, as determined under standard TPK
assay conditions.

At first it was thought that high concentrations of

ATP were inhibiting the enzyme, but, as shown in Figure 13, the inhibition was partially due to changing the Mg++/ATP ratio.

Figure 15 is

another double reciprocal plot which shows that the inhibition due to
ATP under the conditions of these experiments is lowered if the Mg++/
ATP ratio is kept at 0.6.

Apparently if the ratio of magnesium to

ATP is altered from 0.6 in the assay mixture, the enzyme is inhibited
by one or more of the species present under these conditions.

The Km

for ATP, as determined in Figure 14, is 2.85 x 10- 2 M while that
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Fig. 12.--Determination of the optimum magnesium concentration.
The enzyme was assayed by the standard method (see 11 Standard Condition
for Enzyme Assay1 1 ) except that only 0.05 ml of ATP was added and the
amount of magnesium was changed as indicated on the ordinate.
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The enzyme was assayed by the standard procedure (see 11 Standard Conditi on for Enzyme Assay 11 ) except that the amount of ATP added was varied
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same as that in Figure 14.
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Fig. 14.--Determination of Km for ATP, showing the apparent
substrate inhibition. The enzyme was assayed by the standard metbod
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that determined from the data in Figure 15 is 5,9 x 10- 2 M.
Using purified enzyme from the same preparation used to obtain
the data given in Figure 14, a determination of the Km for thiamin was
made from a double reciprocal plot of TOP synthesis versus thiamin
concentration.

The results of this study are given in Figure 16.

can be seen, the Km for thiamin was found to be 4.1 x 10- 6 M.

As

In this

experiment, a range of thiamin concentrations from 1.11 uM to 0.2 uM
was used.
As stated above, the data used in Figures 14 and 16 were obtained
using the same fraction from the electrofocusing column.

This frac-

tion had the highest amount of TPK activity per ml of solution (activity per mg protein was not determined).

Another fraction from this

same preparation (with less TPK activity per ml) was used to obtain
the data given in Figure 17.

The concentration of thiamin was varied

from .089 uM to .889 uM and the concentrations of each inhibitor are
given in the legend to the figure.

The initial velocities were deter-

mined using the standard method of enzyme assay (see "Standard Condi tion for Enzyme Assay"), except only 0.05 ml of ATP solution was used
and the amount of thiamin was varied as indicated above.

It was felt

that the assay might not be linear for an hour at the low concentrations of thiamin being used, so the linearity of the reaction with
time, at the lowest concentration of thiamin used, was determined
(see Figure

4).

The inhibitors were added to the regular assay mix-

ture, as described above, and the reaction was then started by adding
a portion of the enzyme solution.

The amount of TOP synthesized was

determined in the usual way (see "Standard Condition for Enzyme Assay'').
As can be seen, all four inhibitors are competitive with the Ki's of
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Fig. 16.--0etermination of the K~ for thiamin. The enzy~e was
assayed by the standard procedure (see 11 S tandard Condition for Enzyme
Assay 11 ) except the amount of thiamin added was varied as indicated on
the ordinate, and only 0.05 ml of ATP was used. The specific activity
of the thiamin solution was 17,000 cpm/nmole.
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Fig. 17.--Inhibition of pig brain TPK by oxythiamin,
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by the standard procedure (See ''standard Condition for Enzyme Assay")
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and only 0.05 ml of ATP was used. For the determination of inhibition,
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pyrithiamin, butylthiamin, and ethylthiamin, being about the same order
of magnitude as the Km for thiamin.
The kinetics were later studied in more detai 1, taking cognizance
of the fact that in a bisubstrate reaction the kinetics of one substrate are often influenced by the concentration of the other.

Using

an enzyme preparation from step eight, the intial velocities obtained
while varying the ATP concentrations was studied.

The procedure was

the same as that given for Figure 15, except that the ATP concentration was determined both spectrophotometrically and enzymatically (using the hexokinase-glucose-6-phosphate dehydrogenase system) and was
found to be only eighty per cent of the calculated value (0.32 M found
versus 0.40 M calculated).
tion was only calculated.

Previous to this time the ATP concentraIn this experiment five different concentra-

tions of thiamin were used, ranging from 200 uM to 1 uM.
shows the results of this study.

Figure 18

The converging lines indicate that

the KATP found is a constant for the dissociation of a terinary enzymethiamin-ATP complex.

Figure 18 also shows that even though the Mg++/

ATP ratio is maintained at a constant value at the highest concentration of ATP used (0.0322 M). the reaction is inhibited, especially at
low thiamin concentrations (4 uM and 2 uM).

The results of an experi-

ment in which thiamin was the variable substrate with ATP concentration
held constant is given in Figure 19.

The parallel lines obtained

suggest that the reaction proceeds by a

11

ping-pong 11 mechanism.

For this

type of mechanism a reciprocal velocity equation with thiamin as the
variable substrate may be written as:

V

=

Ka

Va

+

1

v

( 1

( 14)
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where Ka= KTh, a= (Th), Kb= KATP, and b = (ATP).

From equation 14
V

it can be seen that the slope of each line is equal to~V

Therefore,

in order to evaluate Ka it is necessary to have a value for V.
the intercept is equal to~

V

( 1

Since

+ ~), it is possible to evaluate
b

V by making a secondary plot of they intercept of each line versus
1/b.

For the secondary plot, they intercept is equal to 1/V and the

slope is equal to Kb/V; thus permitting the evaluation of Kb as well
as V.

This secondary plot is shown in Figure 20.
Purity of the Enzyme
It was decided to use the Beckman Model E, Analytical ultracen-

trifuge in order to try and detect any impurities present in the purified enzyme preparation.

To do this, the protein in a sample from the

electrofocusing column was precipitated with ammonium sulfate.

After

resuspending the precipitate, it was dialyzed against 0.013 glycylglycine for twelve hours.

As noted earlier, dialysis causes the enzyme

to be inactivated and the dialysis, in this case, caused a fifty per
cent drop in specific activity.
in the ultracentrifuge run.

However, the dialyzed sample was used

The run was made at top speed (about

59,000 rpm) in the centrifuge .

A double sector cell was used and

pictures were taken at eight minute intervals.
used.

Schlieren optics were

Two distinct peaks were noted in the pictures and this was ac-

cepted as evidence that the most purified TPK preparations were not
homogeneous.
Another check of the purity was made using enzyme from step eight
which had a specific activity of 83 units/mg protein (the specific
activity was higher than that of the enzyme used in the ultracentrifuge
study) using poly-acrylamide disc-gel electrophoresis.

The standard

92

15

10

Q)

0

Q)

C:

5-

/i

-1/KATP

-50

KATP =

0.055 M

150

200

---1/V = 0.70

0

50

100

1/[ATP] (Mr 1

Fig. 20.--Secondary plot of Figure 19.
line in Figure 19 versus ATP concentration.

250

y intercept of each

93
gel system was used in the experiment and after the electrophoresis
run the protein bands were visualized by staining with c9omassie blue.
The presence of at least five bands of protein was noted, further indicating that the purified enzyme was not homogeneous.

Because of

the inhomogeniety of the pig brain thiamin pyrophosphokinase preparation, no determination of the molecular properties were made.

DISCUSSION
The purification of pig brain thiamin pyrophosphokinase has been
followed by using a direct radiometric assay.

This assay is essential-

ly the same as the one used by Sharma and Quastel (33) .

With most

batches of thiamin - 14c used in this study, the cpm found in the blank
were large when compared to the cpm obtained from the enzyme assay
solutions.

This is in contrast to the results of Sharma and Quastel,

who reported that a "relatively small" value (number of cpm) was obtained in blank experiments.

The number of cpm in the blanks was cut

considerably by the use of thiami n- 14 c which was purified by column
chromatography.

The routine assay, as used in this study, was not as

sensitive as the coupled enzymatic assays used by earlier workers
(e.g. 12,53).

In the standard assay, the lower limit of detection

was about 0.1 nmole of TOP.

In contrast to this, Johnson and Gubler

(12) were able to detect as little as 10 pmoles of TOP with their
standard assay.

However, by using a thiamin solution with a higher

specific radioactivity, the sensitivity of the assay was increased.
For example, using a solution of thiamin having the highest specific
activity available (14.0 mCi/mmole), it was possible to detect as
little as two picomoles of TOP.
It was felt that this direct, radiometric assay was simpler to
use than the older, coupled enzymatic systems, (see e.g. 12,48), since
it alleviated the need to isolate and use several enzymes.

Also, a

direct assay, such as the one employed in this study, has certain
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advantages.

For example, in experiments involving inhibitors, it

would be certain that the results observed are due to effects of the
inhibitors on the enzyme being studied, and the results are not due
to effects on the enzymes used in the assay.

For these reasons, the use

of a direct assay for TPK is desirable.
The procedure used for the purification of pig brain TPK was
adapted from earlier procedures (55,12), although it was enlarged and
modified.

Each step of the isolation procedure used in this work was

carefully studied to determine, insofar as possible, the optimum conditions for enzyme isolation.

In order to determine the efficiency of

the acetone powder preparation (step 1), several attempts were made to
detect TPK activity in brain extracts.

However, under the conditions

studied, no TPK activity could be detected.

The results of experiments

using 14c-TDP indicated that the extracts of brain contained considerable TOP-cleaving activity; enough to hydrolyze all the TOP produced in
the TPK reaction.

Attempts to inhibit this TDPase activity failed, so

it was assumed that the TPK activity of the brain extracts was not detectable because of the TDPase activity which was present.

These re-

sults were in contrast to those of Sharma and Quastel (33) who were
able to study the phosphorylation of thiamin in brain extracts.

Under

the conditions of their experiments, they could detect no TDPase activity.

It is possible that the explanation for this difference in re-

sults lies in the way the extracts were prepared.

After homogenization,

Sharma and Quastel centrifuged at 44,000 rpm,whereas, in this work
the fastest centrifugations were done at 17,000 rpm.

It seems likely

that the faster centrifugation causes the TDPase activity to precipitate, leaving the TPK activity in solution.
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In this work it was found routinely that the acetone powder extracts were capable of synthesizing approximately 0.5 x 10-7 moles
of TOP per gram of acetone powder (see table 7).

This is about one

third the rate reported by Johnson (32) for rat brain TPK, and half
the rate reported by Mano for rat liver TPK (55).

Johnson (32) re-

ported that rat liver TPK was capable of synthesizing about

7

x 10- 7

moles of TOP per gram of powder per hour, or about ten times the rate
found for brain acetone powder in this work.

However, it should be

noted that attempts to repeat the work of Johnson and Gubler (12, 32)
using the TPK assay described in this study always resulted in lower
specific activities of TPK than those reported by Johnson and Gubler
(12) for comparable steps.

The reason for the differences in the

specific activities determined in the two studies is not known, but
it could be due, at least in part, to the two different assay systems
used in these studies.
It was noted that in the early stages of purification the pig
brain TPK appeared to behave exactly the same as the rat brain TPK.
The specific activity of the acetone powder extracts was very close
and this continued at least to the ammonium sulfate fractionation step.
TPK extracted from beef brain acetone powder was also quite similar,
but the specific activity in the acetone powder extracts was lower.
For this reason pig brain was selected for use in this study.
The protamine sulfate treatment, though it usually gave an increase in the total TPK activity of the solution, had very little effect on the following steps, except for the acid treatment, step 7.
If the enzyme solution was previously treated with protamine sulfate,
the loss of activity during the acid treatment was held to a minimum.
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It would seem from this that removal of the nucleic acids increases the
stability of the TPK at low pH values.

The next step in the purifica-

tion, the heat treatment, used the same procedure outlined by both Mano
(55) and Johnson and Gubler (12).

However, in this study the treat-

ment did not work as well as it did for the earlier workers.

Therefore,

the conditions of the heat treatment were studied in detai 1 (see figures 7, 8, and 9) to see if better results could be obtained, but it
was found that the optimum conditions were the same as those given by
Mano (55) and by Johnson and Gubler (12).

It was observed that the

most critical factor in the heat treatment, of the three studied (pH,
temperature, and time), was the temperature of the incubation (see
figure 8).
Two steps 1n the purification procedure, desalting with Sephadex
G-25 and the acid treatment, resulted in a decrease in the specific activity.

They were included because they were necessary for the next

step, alumina C?S' fractionation.

It was observed that after the pH

was lowered to 4.3, it was necessary to allow the solution to stand
overnight (at least 8 hours) in order to obtain best results from the
alumina C2( step.

As mentioned earlier, including the protamine sul-

fate treatment kept the loss of activity during the acid treatment to
a minimum.
The fractional adsorption of TPK on alumina C'( worked much better
than using the alumina C¥ in a column, as was suggested by Mano (55).
The fractional adsorption process could be completed in a few hours
and the results were easily reproducible from day to day.

The TPK

activity was always completely adsorbed by the second addition of
alumina.

After the TPK had been adsorbed on the alumina, an important
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point was to allow it to stand in the cold room (3°) for at least five
hours, otherwise the elution of the activity was not consistent and
the specific activity of the TPK in the eluate would be low.
The gel filtration of the combined fractions of the alumina Cc,"'
fractionation served two purposes:

First, during this step the salt

concentration of the protein solution was lowered enough to permit the
protein to be further purified by electrofocusing, and second there
was an increase in specific activity of the TPK. The only problem with
the procedure was a low recovery of the enzyme activity (66 per cent).
The electrofocusing column worked very well since it was possible
to obtain about a ten-fold increase in specific activity during this
step (see Table 7) with over fifty per cent recovery of activity.

The

electrofocusing runs were also useful in giving information on the pI of
TPK.

If the electrofocusing column has equilibrated, the enzyme activi-

ty should be found in the fraction whose pH corresponds to the pl of the
enzyme.

In the different runs made, using the electrofocusing column,

the highest enzyme activity was found in the fractions with pH's from

3,9 to 4.4, indicating that the pI of the pig brain TPK is somewhere
in that range.

Some of the variation in the observed pI was probably

due to differences in the volumes of the fractions collected and to
the difficulty experienced in determining the pH of the fractions.

(The

pH readings in the concentrated sucrose solutions were quite erratic.)
At this point in the preparation, the enzyme was quite unstable, especially in solutions of low ionic strength.

The procedure used in the

purification gave an enzyme preparation with a specific activity of
about 100 units/mg protein.

This was a 260-fold purification over the

original acetone powder extract (see Table 7),

Comparing this to other
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TPK preparations from mammaliam tissues, Mano (55) has reported a
120-fold purification of rat liver TPK.

Johnson and Gubler (12) have

reported a twelve-fold purification of rat brain TPK, and after the
purification part of this work had been completed, Hamada (59) reported
a 1,000-fold purification of pig heart TPK.

Most of the other work

concerning the purification of this enzyme has been done on yeast TPK.
The most highly purified yeast TPK preparation is that of Thoai et al.

(49) who have reported a 200-fold purification.

Therefore, the 260-

fold purification obtained in this work compares very favorably with
other purifications reported in the literature.
An interesting feature of pig brain thiamin pyrophosphokinase
at any stage of purification is its instability during dialysis.

It

seems unusual that an enzyme which can withstand an acetone treatment
or which is stable for up to nine hours at 37° could be denatured by
dialysis.

It is possible, therefore, that the TPK may be associated

with some small component which is essential for activity, but which
is, at least, partially removed during dialysis.

One piece of evidence

in favor of this possibility was noted during an attempt to determine
the molecular weight of the TPK using a Tanford column.

During this

experiment a peak of adsorbance was noted which occurred at about the
same position as the marker compound,

This peak

of adsorbance could have been due to some essential nucleotide or coenzyme which is necessary for enzyme activity.
The pH optimum of the purified pig brain TPK in phosphate-glycylglycine buffer was quite broad, extending from 8.3 to 9.3 under the
conditions tested.

The enzyme activity in the more acid pH range

appeared to be inhibited by tris buffer and pH-activity curves similar
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to that reported by Johnson (32) for rat brain TPK in tris buffer were
obtained.

The pH optimum for rat ~rain TPK in glycylglycine buffer was

found to be 7.8 (12).

The rat liver TPK in tris buffer with magnesium

and ATP as substrates, had a broad pH optimum extending from about
6 to 8.

However, with the rat liver TPK, the highest activity was

obtained when divalent manganese and ATP were used, and the pH was
about 8.5.

The reasons for differences in the observed pH optima of

the two brain and liver TPK 1 s are not known.

However, they may be due,

at least in part, to the different stages of purification of the enzymes
involved, as well as the different assay conditions employed.

However,

the same enzyme from different species and different tissues may have
quite different properties.
The effect of magnesium ions on the enzymatic activity was studied
in some detai 1.

If the ATP concentration was held constant, while the

amount of magnesium was varied, an optimum concentration of magnesium
to obtain maximal TPK activity was observed, with the enzymatic activity dropping quite rapidly on either side of this optimum (Figure 12).
The same type of curve was observed if the magnesium concentration was
held constant while the ATP concentration was varied (Figure 13).

The

results observed with the purified pig brain TPK are very close to
those observed for purified rat liver TPK by Deus et al. (57).

How-

ever, Mano and Tanaka (56) found quite different results with purified
rat liver TPK.

They reported a rather broad optimum for magnesium with

the shape of the curve being quite different from that found in this
study, and that reported by Deus, et~-

The shape of the curve for

manganese, however, was quite similar to the curve found for magnesium
in the present study.
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The drop in activity when the magnesium/ATP ratio was changed in
either direction from its optimum of 0.6, caused some trouble during
the attempt to determine a Km for ATP.

As is shown in Figure 14, it

first appeared as though the high concentrations of ATP were causing
inhibition.

However, the observed inhibition was due, in part, to the

fact that the ratio of magnesium to ATP varied from 0.6 during the experiment.

Figure 15 shows that if the ratio of magnesium to ATP is

held constant at 0.6, there is not as much inhibition of the enzyme activity by higher concentrations of ATP.

However, as shown in Figure 18,

at lower concentrations of thiamin the reaction is inhibited by high
concentrations of ATP.

It is interesting to note that Deus et al. (57)

found the optimum ratio of magnesium to ATP to be 0.67 for the purified
rat liver TPK, a value very close to the value found for the pig brain
TPK in this study.
To date very little had been done to study the kinetics of the
reaction catalyzed by TPK.

This has probably been due, at least in

part, to the lack of any homogeneous enzyme preparation.

With the

exception of Thoai et~- (49) authors have been content to report Km's
for thiamin and ATP without taking into account the fact that the concentration of one subs~ate may affect the value of the Km of thesecond substrate.

As shown in Figures 15, 16, and 17 it is possible to

obtain values for a Km for ATP and thiamin as well as constants for
inhibition by thiamin antagonists.

But as can be seen from figures

18 and 19, the kinetics of this reaction are, in actual fact, rather
complex.

The data shown in Figures 18 and 19 indicate that the reac-

tion proceeds by two contradictory mechanisms.

The converging lines

in Figure 18 show the formation of a terinary complex, whereas the
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parallel lines of Figure 19 indicate that no terinary comples is formed.

One explanation of the apparent conflict presented by the differ-

ing graphs is given by postulating the following mechanism:
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be understood that the above, postulated mechanism should

be regarded only as a tentitive scheme which should not be accepted as
the true mechanism without considerably more evidence being presented
to support it.

The mechanism is given at this time mainly to facili-

tate the discussion of the results of the experiments concerning the
kinetics of TPK.

In the above mechanism E' represents an enzyme in-

termediate, possibly a pyrophosphoryl enzyme, which has accepted the
pyrophosphate group from ATP and which in turn may combine with thiamin to give TOP.

The major portion of the reaction would proceed

through the enzyme intermediate.
would proceed via a
formation.

11

Therefore, the primary reaction

ping-pong 11 mechanism, with no terinary complex

An alternate explanation for the converging lines seen in

Figure 18 is that the reciprocal velocity versus reciprocal ATP concentration was plotted when the actual substrate for the enzyme was probably MgATP complex (see Figures 12 and 13).

Under the conditions of

the experiments depicted in Figure 18 it was not possible to estimate
the concentration of the MgATP complex; but it is possible that if a
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family of double reciprocal plots (velocity versus MgATP complex
concentration) were made at several different thiamin concentrations,
the lines could turn out to be parallel instead of converging.

The

fact that the K'ATP found in Figure 18 is smaller than the KATP found
in Figure 20 shows that the binding of one substrate to the enzyme
enhances the binding of .a second substrate.

At the present time the

high K's for ATP observed with the brain enzyme cannot be explained,
but it appears that they couldn't accurately reflect the constants for
the enzyme in vivo.

It has been reported (71) that the concentration of

ATP in brain is about three millimolar.

Therefore, if the observed K's

for ATP were correct, the TPK in vivo would have almost no activity.
The KTh determined in Figure 19 is a dissociation constant for the
E'•Th complex.

This value is quite close to the "Km" for thiamin det-

ermined in Figures 16 and 17.
As can be seen from the above discussion, the "Km" of ATP varies
with the thiamin concentration and the "Km'' of thia:nin varies with the
ATP concentration.

Therefore, the earlier results given in the liter-

ature must be considered in this light.

It is possible that this may

help to explain some of the contradictory results which have appeared
in the literature.
The inhibitcr constants given in Figure 17 probably give an indication of the ability of the thiamin antagonists to compete with the
vitamin as acceptors of the pyrophosphoryl group from the derivitized
enzyme.

This would explain why competitive inhibition was found in

each case.

The fact that the most potent inhibitors all contain an

amino group at position four on the pyrimidine ring supports the theory
of Cerecedo (79) that the amino group at position four on the pyrimidine
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ring is necessary for effective binding of the substrate to the enzyme, (E').
The fact that the kinetics of thiamin are effected by ATP concentration indicates that the values for the inhibitor constants may
also depend on the ATP concentration.

This makes it difficult to com-

pare the inhibitor constants found in this study with those reported
in the literature, since the ATP concentration used in this study was
higher than was used in previous studies.

It is interesting that

both thiamin analogs which have been reported to cause neurological
symptoms, butylthiamin and pyrithiamin, have Ki's on the same order
of magnitude as the Km for thiamin, even though pyrithiamin is a much
more effective antimetabolite.

The Ki value reported for butylthia-

min is the first reported in the literature for this compound.

This

finrnng indicates that the effectiveness of pyrithiamin as an antithiamin agent cannot wholely be ascribed to its effect on TPK.

This

conclusion is strengthened by the fact that ethylthiamin, which has
been reported to have thiamin-type activity~ viv~ (72) and~ vitro

(56) also was found to have a Ki of the same order of maqni~ude as
pyrithiamin.

However, oxythiamin, which is a relatively (compared

to pyrithiamin) poor antithiamin agent, has a Ki four hundred times
greater than pyrithiamin.

This indicates that there may some corre-

lation between effectiveness as an antithiamin agent and the ability
to compete with thiamin as an acceptor of pyrophosphate.
At this time it is not known if the inhibitors were phosphorylated by pig brain TPK, although some evidence suggests that the pyrophosphate esters were formed (12,21,73).

As mentioned earlier, the

fact that Koedam and Steyn-Parve (73) showed that pyrithiamin
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pyrophosphate was produced by purified rat liver TPK, lends credence to the idea that the purified pig brain TPK may also catalyze the formation of pyrithiamin pyrophosphate.
The direct proof that the antagonists are phosphorylated by
TPK would require that the phosphorylated compounds b~ isolated and
identified as products of the TPK reaction.

This has not yet been

done with brain TPK.
This study lends support to the concept that the antagonists
with high affinity for TPK (pyrithiamin, butylthiamin, and ethylthiamin) may exert their inhibitory effects by competing with thiamin for TPK, thus preventing the phosphorylation of thiamin.

On

the other hand, as discussed by Gubler (17), oxythiamin probably exerts its main inhibitory effect after it is phosphorylated by competing with TOP for binding to the various TOP-requiring enzymes.

Yet,

it is still possible that the main point of inhibition of all the
thiamin antagonists discussed is at the phosphorylation step, with
oxythiamin further inhibiting by binding to TOP-requiring enzymes.
Considering that a five to one ratio of pyri thiamin to thiamin is
sufficient to bring about the symptoms of thiarnin deficiency,

whereas

a two hundred to one ratio of oxythiamin to thiamin is required to
do the same (16, 17), it would appear that the most impor 1 ant thing
is to be sure that a large enough excess of antagonist is present to
insure that the phosphorylation of thiamin is inhibited while the
antagonist itself is, presumably, being phosphorylated.

Whatever the

case may be, it can be stated with certainty that the actions of the
antagonists cannot be completely explained on the basis of their effects on TPK.

SUMMARY
The direct, radiometric, assay procedure developed by Sharma and
Quastel {33) for TDP- 14c has been used to follow the purification of
pig brain thiamin pyrophosphokinase.

No enzymatic activity could be

detected in brain homogenates because of the presence of TDPase.

Us-

ing a ten-step purification procedure, a 260-fold purification over an
extract of the brain acetone powder was achieved.

This compares favor-

ably with other procedures reported in the literature for the purification of TPK from other sources.

This procedure was a modification of

those used by Mano (55) and Johnson and Gubler ( 12).

The enzyme was

found to have a broad pH optimum, extending from 8.3 to 9,3 in phosphate-glycylglycine buffer.

The purified TPK was found to have maximal

activity if the ratio of magnesium to ATP was 0.6.

Any deviation in

either direction from this ratio caused an inhibition of the enzymatic
activity.

A study of the kinetics revealed that the reaction probably

follows "ping-pong'' kinetics although the results are somewhat anomalous.
However, three constants associated with the enzyme were evaluated.
Pyrithiamin, oxythiamin, butylthiamin, and ethylthiamin were found to
be competitive inhibitors of the purified TPK.

It was not determined if

the inhibitors are phosphorylated by TPK, although some evidence reported by other workers (12, 19,56,72,21,73) indicates that they probably
are.

Radioactive TOP was identified as a product of the standard assay.

The isoelectric point of the purified enzyme was found to be about pH
4.2 using the technique of isoelectrofocusing.
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The purified enzyme was examined in the analytical ultracentrifuge and two peaks were noted.

It was also checked by disc-gel elec-

trophoresis and five bands of protein were observed.

It was assumed,

therefore, that the most highly purified enzyme preparations were not
homogeneous.
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ABS TRACT
Pig brain thiamin pyrophosphokinase (TPK) (ATP: thiamin pyrophosphotransferase, EC 2.7.6.2) was purified 260-fold over extracts
of brain acetone powder. The purification was followed using a direct, radiometric assay. As determined in an analytical ultracentrifuge and by disc-gel electrophoresis, the most highly purified enzyme preparations were not homogeneous.
The purified enzyme has a broad pH optimum extending from 8.3
to 9.3 in phosphate-glycylglycine buffer. It has an isoelectric point
at about pH 4.2. For optimal enzymatic activity, the ratio of magnesium - to ATP must be 0.6. Any deviation from this ratio causes a
rapid drop in enzymatic activity. A study of the kinetics of the
reaction revealed that the enzyme functions via a "ping-pong" mechanism. Two dissociation constants for ATP and one for thiamin were
evaluated. Pyrithiamin, oxythiamin, butylthiamin, and ethylthiamin
were competitive inhibitors of thiamin.

